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ABSTRACT 
 
 
Candida albicans is an opportunistic fungal pathogen that may cause mucutaneous infection 
and/or disseminated candidasis if the host defense system is impaired (such as those in HIV 
patients). Cell surface of C. albicans is the frontier where initial interplay between host-pathogen 
takes place and therefore is of great importance in understanding the mechanism of host-
pathogen interaction. MALDI-TOF-MS analysis of intact fungal cells yielded mass signatures 
for rapid species differentiation, strain grouping and yeast morphogenesis monitoring.   
 
Cell surface biotinylations at low temperature (4°C), enzymatic digestion of the intact fungal cell 
surface proteins (“whole cell shaving”), biotin-avidin affinity enrichment of biotinylated 
peptides, liquid chromatography mass spectrometry (LC-MS) based proteomic approach were 
employed for unambiguous identification of cell wall/cell wall associated proteins and the 
exposed peptide segments of these proteins. SILAC (Stable Isotope Labeling by Amino acids in 
Cell Culture) based CWP quantification analyses were performed to monitor CWP accumulation 
level change in response to hyphae induction. Information on surface exposed peptide segments 
and regulation of cell wall/surface protein during morphogenesis provided new candidates to the 
pool of potential peptide targets for protective vaccine development. 
 
A New type of “fluorous” (fluorinated alkane) affinity gained popularity due to its low level non-
specific protein/peptide binding. Fluorous labeling reagents that target primary amine groups in 
proteins/peptides were synthesized and characterized. The acid labile linker in the labeling 
reagents allows cleavage of the bulky fluorous tag moiety and the long oligo ethylene glycol 
(OEG) spacer after fluorous affinity purification. Upon collision induced decomposition, the 
 xv
labeled peptide ion yielded a characteristic fragment that could be retrieved from the residual 
portion of fluorous affinity tag, and serve as a marker to indicate that the relevant peptide had 
been successfully labeled. Results showed that both the protein/peptide labeling and affinity 
enrichment/separation process were highly efficient. 
 
Keywords 
Candida albicans, Yeast differentiation, MALDI-TOF MS, Fluorous labeling reagent, LC-MS, 
Cell surface proteome, Surface biotinylation, SILAC 
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CHAPTER 1 
 
Introduction 
 
1.1 Overview of Candida albicans 
C. albicans is a member of yeast kingdom that possesses basic biological features for the yeast 
species such as a singular cell with an oval shape, reproduction by budding or fission. However, 
its opportunistic pathogenicity distinguished C. albican from its benign relative Saccharomyces 
cerevisiae that is commonly used as baker’s yeast in our daily lives.  C. albicans commensally 
exists in most healthy human populations and can usually be observed in the oral cavity, gastro-
intenstinal and urogential tracts. The tipping point of the balance relies on both the host immuno-
system and the fungal traits. This facultative pathogen may turn into a pathogenic agent of 
infection if the host defense system is impaired. The severity of the fungal infection, depending 
on the nature and extent of the impairment of the host immune-system, can vary from superficial 
mucocutaneous infections to life-threatening, invasive infection (124). Over the last few decades, 
reports of human fungal infection have been increasing at an alarming rate worldwide (132), 
especially in immuno-compromised patients like HIV infected individuals, patients undergoing 
transplanting surgery, chemotherapy and other immuno-suppressed treatments (25, 45). 
Candidiasis is now the fourth leading cause of nosocomial bloodstream infections in the US (83), 
and for many years the overwhelming leading cause of this disease has been C. albicans. 
C. albicans is a dimorphic organism, which has the ability to transform singular budding yeast to 
filamentous hyphae cells under environmental factors such as growth temperature at 37°C, serum 
medium and near neutral pH (9). This morphogenic development is recognized as a key 
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virulence factor of the fungal species during infection as it enables attacks on host cells either 
through epithelium invasion or endothelium barrier breaching (29) (82). As a matter of fact, it 
was shown that non-filamentous mutants were avirulent in murine models (88). One of the key 
features during the morphological change from yeast to hyphae is the cell wall remodeling, 
which is companied not only by composition change of cell wall but also by differential 
regulations of cell wall proteins. Previous study showed that it was easier for C. albicans hyphae 
cells to escape from the capture of mammalian macrophages than yeast cells (88). Information 
on the quantitative change of cell wall protein expression level during the conversion may shed 
lights on the path to understand what renders the hyphae more virulent compared to the yeast 
form morphogenesis.   
 
The cell surface is of critical consideration in the attempts to understand morphogenesis and 
immunologic target identification, as the cell surface is the forefront where the initial contact 
between host-fungus occurs and such contact may induce immune response from the host. 
Understanding of the pathogen-host interaction may provide insight into the functional 
mechanism of fungal invasion. Mechanisms by which C. albicans cause disease are still largely 
unknown. Although progress has been made on identification of immunologic targets that can be 
recognized by either antibodies or cell-mediated immune defenses (30) more information is 
needed before immuno-approaches to prevention and treatment of candidiasis become a reality.  
 
1.2 MALDI -TOF Mass Spectrometry 
Matrix-assisted laser-desorption/ionization (MALDI) was first introduced in late 1980s by Karas, 
Hillenkamp, (76) (78) and Tanaka (128). This revolutionary method for ionizing large molecules 
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blazed new trails in the mass spectrometry field along with another parallel ionization technique, 
electrospray ionization (ESI), ushered by Fenn (42). Since then both of these two techniques 
have been the most successful ionizing methods for large bio-molecules such as proteins, 
nucleotides, and carbohydrates. In MALDI, analytes are usually co-crystalized with certain types 
of matrix, which transfer the absorbed large excess of laser energy (UV or IR wavelengths) to 
the neighboring analyte molecules during the excitation process. A plum of ions was released 
upon laser irradiation, accelerated by electrical potential and analyzed by a mass spectrometer as 
illustrated in Figure 1.1. 
 
Photochemical ionization (PI) (39) and cluster ionization (CI) (77) have been proposed as the 
two major models for explaining the mechanism of MALDI process. Matrix molecules were 
initially excited through energy pooling and multiphoton extraction from laser irradiation in the 
PI model. Analyte ions were consequently generated after protons were transferred to the analyte 
molecules. The PI model has been commonly accepted as the primary mechanism for MALDI , 
although it can not be applied to explain some experimental phenomena such as matrix 
suppression effect (80) and “sweet spot” (87). Contrary to the PI model (39), the CI model (77) 
redefined the origin of analyte ions by proposing a large protonated analyte cluster clouded with 
excessive amount of matrix molecules. Singly charged analyte ions were released from the large 
analyte-matrix cloud after “shaking off” neutral matrix molecules in gas phase. The ionization 
process in the CI model is analogous to the solvent desolvation stepin ESI. However, the CI 
model failed to explain why large biomolecules were singly charged in the gas phase while the 
same type of molecules were multiply charged in ESI. Recently, Chen and co-workers (20) 
proposed an energy transfer induced disproportionation (ETID) model which enabled them to 
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Figure 1.1. Schematic overview of matrix-assisted laser desorption/ionization (MALDI). 
 
 
 
 
 
 
 
 
 
 5
explain the observation of  equal number of positive and negative analyte ions in MALDI. 
 
Matrix selection plays pivotal roles in the success of MALDI analysis. Matrices are usually 
aromatic compounds with low vapor pressure. Nicotinic acid (NA) was the first matrix applied in 
ionizing proteins and peptides (78). A broad range of matrices have been surveyed to determine 
if a compound is suitable for the ionization of a particular type of analyte molecule. For example, 
picolinic acid (PA) and 3-hydroxypicolinic acid (HPA) have been used for oligonucleotides and 
DNA analyses, (129) (140) 2,5-dihydroxybenzoic acid (DHB) for oligosaccharides, (127) α-
cyano-4-hydroxycinnamic acid (CHCA) for peptides (8), and sinapinic acid (SA) for proteins 
(7). In addition to matrix selection, sample preparation is also an important factor for a 
successful MALDI analysis. The typical molar ratio of matrix-to-analyte is kept between 500 : 1 
and 5000 : 1, (62) in order to ensure a  good signal-to-noise ratio while minimizing the “matrix 
effect”. Also, co-crystallization of a mixture of analyte and matrix is critical in analysis. 
Unevenly formed co-crystals can cause poor reproducibility due to the presence of “sweet spots”, 
only from which good quality mass spectrum may be obtained. “Thin-layer” depositing 
technique can improve the co-crystallization process by slow evaporation of low volatile solvents 
such as acetone and acetonitrile (134). Upon irradiation by a focused laser beam, the matrix and 
the analyte molecules embedded in the co-crystals leave the MALDI target plate and enter into 
the gas phase in the form of a plume of ions and neutral molecules. Those singly charged ions 
are then accelerated through an electronic potential field, separated on the basis of their 
molecular weight and finally recorded at a mass detector. 
 
1.3 Advantages and challenges in microbe identification by MALDI-TOF MS 
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World-wide infections caused by various microorganisms have been constant threats to human 
health, even though progress had been made in combating those infections by new inventions in 
medicine.  Application of mass spectrometry based methods in microorganism detection has 
been fueled by the advances in mass spectrometry instrumentation recently. Short analysis time 
(a few minutes) is a major advantage of MS-based characterization of microorganism when 
compared with other methods such as the classical polymerase chain reaction (PCR) based 
approaches. Moreover, the MS-based methods usually do not pre-specify targets, whereas DNA 
primer designs in PCR require predetermined targets. MS spectral data can be readily processed 
and incorporated into a reference library, which can subsequently be searched to identify 
unknown samples (67).  
 
The first mass spectrometry based application for bacteria identification was reported in 1975 by 
Anhalt et al (3), who demonstrated the feasibility of differentiating pathogenic bacterial species 
via pyrolysis-mass spectrometry (Py-MS). Basile et al (6) reduced the analysis time of bacterial 
samples to minutes by combining thermal hydrolysis and methylation step with Py-MS. 
Characteristic mass spectra were also obtained through fast atom bombardment mass 
spectrometry analysis of lysed bacteria (60). It was not until the late 1990s that MALDI and ESI 
were introduced to generate mass spectral data for bacterial species (63) (24) and viral species 
(34). Since then, MALDI-MS analyses of toxigenic and pathogenic bacteria were extensively 
reported in the literature(58) (139) (64, 92, 121) (133, 141). Experimental factors that potentially 
affect the quality and reproducibility of the mass spectra obtained from intact whole bacteria 
cells were defined for identification and species differentiation (64). Bacterial species readily 
yield abundant peaks in mass spectra without prior sample treatment. Several automated MALDI 
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mass spectra comparison programs were also developed to facilitate rapid identification and 
speciation of intact bacteria. Mathematical algorithms in automated spectra comparison 
programs were usually based on a cross correlation between two mass spectra (5) or derived 
from a statistical test of significance with reliance on specific bio-makers (38, 46, 67, 116). 
Cluster analysis such as Phylogenetic Analysis Using Parsimony (PAUP*) had been employed to 
compare the MALDI mass spectra of Aeromonas species and determine the relationships among 
the analyzed species (35). Principle component analysis (PCA) is another popular multivariate 
analysis which can be employed to extract features in dataset generated from mass spectra and 
project each spectrum to a single spot on a PCA plot (57). Compared to ESI-MS, rapid MALDI-
MS analysis has several advantageous features: 1. there is no clogging problem in the ion source; 
2. mostly singly charged ions simplify the acquired spectrum (32).  
 
Compared to the growing number of bacterial analysis by MALDI, analysis of fungi was rarely 
reported. A few reports in the literature showed varying degree of success (2, 21, 66, 86). If the 
fungal cell wall is untreated, very few peaks appear on MALDI spectra intact fungal cells as a 
result of low yield of medium size ions (5000 – 15000 Da).  To address this problem, partial 
disruption of cell wall matrix may be necessary. Cell wall digestion is one of the methods that 
facilitate MALDI-MS analyses of fungal species (43). Other treatments such as strong acid 
extraction and detergent solubilization have also been employed (43). These fungal cell wall 
pretreatments were usually time consuming and not entirely compatible to MALDI-MS analysis 
due to the suppression effect of detergents. Development of simple MS-friendly sample 
treatment method is an important consideration in fungal analysis by MALDI-MS.  
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1.4 Organization of the cell wall of C .albicans 
The C. albicans cell wall is a rigid matrix that mainly consists of polysaccharides (about 80-
90%) represented by β-1,3 and β-1,6 glucans, chitin and mannan. Proteins (6-25%) and a small 
amount of lipid (1 to 7%) are also integrated into the cell wall (19). The cell wall is partitioned 
into several layers distinguished by different densities when studied by electron microscopy. Cell 
wall of C. albicans is usually composed of   three to eight layers (112). An electron-dense outer 
layer space is mainly composed of mannoproteins, which can be detected by concana-valin A 
(ConA) labeling (90) or specific antibody (69). The electron transparent inner layer is largely 
composed of a net work of highly branched polysaccharides and a small number of proteins. 
Yeast and hyphae forms share similar percent composition of the cell wall, although the relative 
amounts of individual component differ significantly (15). The cell wall is highly dynamic and is 
involved in almost all aspects of the biology and the interactions of this fungus with the host (18) 
(19) while it maintains a balance between rigidity and plasticity. The rigidity of the cell wall 
provides strong protection for the intracellular components against environmental stress, while 
the plasticity allows the cell wall to adapt to different stages of development during 
morphogenesis of yeast to hyphal forms or yeast to pseudohyphal forms. The rigidity of the cell 
wall is largely attributed to β-glucans and chitin near the plasma membrane (74) (93, 110). 
     
1.5 Cell wall proteins and their functions in C. albicans 
Besides the role in maintaining the architecture of the wall, polysaccharides, the major 
component of the cell wall, may also serve as ligands for receptor proteins from host immune 
cells (33) (44, 52, 100). However, the protein population of the cell wall is more likely to 
distinguish C. albicans as pathogenic yeast from non-pathogenic S.cerevisiae (124). The outer 
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layer of the cell wall is replete with various mannoproteins, which are either covalently bound to 
the inner layer of glucan/chitin networks through  β-1,3 and/or β-1,6 linkage or loosely 
associated with cell wall matrix (74, 110). There are two classes of covalently bound cell wall 
proteins (CWPs): GPI (Glycosylphosphatidylinositol)-CWPs and Pir (Proteins with internal 
repeats)-CWPs. GPI-CWPs are those proteins with C-termini linked to the reducing end of β-1,6 
glucan chain via a phosphodiester bond, which is then integrated into a inner flexible network of  
β-1,3 glucan chains or chitin chains (72, 81). In fungi, some of those GPI proteins are released 
from the membrane and incorporated with the cell wall matrix (48, 56). The GPI-CWPs can be 
extracted through hydrolysis of the phosphodiester bond using HF-pyridine. Pir-CWPs (130) are 
linked directly to the network of  β-1,3 glucan chains without any bridging from of β-1,6 glucan 
and can be cleaved from the glucan chains by NaOH treatment(75, 99). Despite significant 
amount of studies on GPI-CWPs and Pir-CWPs, information is very fragmentary on other CWPs 
covalently bound either to β-1,3 glucan or chitin via uncharacterized linkages. Those proteins are 
usually extracted through enzymatic treatment like Quantazyme (β-1,3 glucanase) and/or 
exochitinase digestion in which  by the polysaccharide moieties of the glycoproteins were 
destroyed (110). Additionally, a large set of CWPs do not have strong attachment to the cell wall 
matrix (or connected to the covalently bound CWPs merely through disulfide bond). Some of the 
proteins related to the cell wall are viewed as secreted proteins (95) (84) because they are usually 
also observed in culture medium. Hot sodium dodecyl sulfate (SDS) buffer containing reducing 
reagents (such as dithiolthreitol) is commonly used to strip those noncovalently associated CWPs 
from the cell wall matrix. 
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Bona fide cell wall proteins are accepted as those that meet the following criteria (115): 1. 
Proteins have a secretory motif (N-terminal secretion signal peptides). 2. Proteins have other 
characteristic features such as GPI-binding motif or inner repeats in addition to their 
glycosylation modifications. Based on these standards, hundreds of cell wall proteins in C. 
albicans were predicted from ORFs analysis (31). This paradigm, however, has never been 
challenged with the accumulating evidence of detected nonglycosylated proteins (37, 110) and/or 
numerous proteins without signal motif on the surface (103). Therefore, the concept of cell wall 
protein should be redefined based on experimental findings in order to accommodate those non-
canonical wall proteins. 
 
Even though the fungal cell wall is comprised of highly diverse proteins, five main functions 
have been assigned to those CWPs. 1). Some proteins are involved in enzymatic degradation of 
large molecules which could serve as a nutritional source. Other protein enzymes play roles in 
maintaining the architecture of cell wall polymers by their involvement in the pathways of 
polysaccharide degradation/synthesis;(19) 2). Some proteins are involved in initiating “cross-
talk” with host cells. Adhesins are typical fimbriae mannoproteins that facilitate the attachment 
of the fungal cell to host cell (epithelial, endothelial or platelets) through four major recognition 
systems; (115) 3). Antigenicity is another important function shared by different cell wall 
proteins from both yeast and hyphal cells (17). Those proteins with immunogenic motifs are 
good candidates for vaccine development; 4). Certain cell wall proteins may contribute to 
virulence factors on cell surface as evidenced by their involvement in pathogenesis (47). 
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1.6 ESI-MS based proteomic approach to studying cell surface of C. albicans and current 
challenges  
In this post-genomic era, advancement in proteomics has been fueled by the development of 
versatile mass spectrometry instrumentation. The term “proteomics” was coined by Marc 
Wilkins in 1994 (36, 138) with a notion of 2D gel based analysis of total protein expressed by a 
genome. The extension of this concept, however, is far more comprehensive then its original 
definition and still rapidly expanding driven by the demand for answering new questions arising 
from biology studies. Proteomics is now related not only to protein sequencing and proteome 
profiling in a certain compartment of an organism, but also to the study on the dynamic change 
of protein accumulation levels under various conditions, post modifications of proteins and 
protein-protein interactions. MS-oriented proteomics is undoubtedly the mainstream in studying 
proteins in biological field that is benefited from discovery and development of protein 
ionization techniques. 
 
Two “soft” ionization techniques, ESI (42) and MALDI, (76) are most commonly employed 
mass spectrometry based analyses of proteins and peptides. In ESI, high electric potential is 
applied to analyte solution to form charged droplets. Attracted by a potential gradient and a 
pressure gradient along the ion passage, the droplet undergoes a desolvation process, which leads 
to downsize the droplet. The process continues by constant evaporation of the solvent (and ions 
in some cases) until fully desolvated ions are formed. ESI-MS is usually coupled with liquid 
chromatography (LC) to form an on-line LC-MS system that has become the most powerful 
instrumentation for peptide sequencing in proteomics field (Figure 1.2.). 
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Figure 1.2. Schematic presentation of liquid chromatography (LC)-mass spectrometry (MS) 
analysis of a peptide mixture in positive mode. 
 
 
 
 
 
 
 
 
 13
In most tandem mass spectrometry-based proteomic approaches, the proteins are chemically or 
enzymatically digested to yield smaller peptides and these peptides are subsequently analyzed by 
tandem mass spectrometry. Database searches are performed on the tandem mass spectra of 
peptides to determine the peptides’ amino acid sequences, and protein identification is achieved 
by the determination (via database search) of the unique peptide(s) derived from this protein 
(135). The C. albicans protein sequence database (available from 
http://www.candidagenome.org/) facilitates the identification of C. albicans proteins via database 
search. 
 
The advancement of MS techniques and availability of the full genome sequence of C. albicans 
seem to make it theoretically straightforward to catalogue cell wall proteins of the fungus. 
However, little progress has been made. Part of the reason is that the heterogeneity of the cell 
wall proteins (covalently linked to cell wall) makes sample preparation a formidable task. 
Complicated sequential fractionation is required to isolate those proteins from the 
polysaccharides network under various chemical and/or enzymatic treatments either from intact 
cells (4, 16, 79, 89, 123) or cell wall pellet after cell lyses (70, 110, 132) (40, 71, 98). The 
fractionated CWPs were further separated by two-dimensional gel electrophoresis (2D-PAGE) 
before LC-MS analysis. This fractionation based sample preparation method may provide some 
additional information about how CWPs are linked to the network of polysaccharides. 
Unfortunately, the detection of the identical wall proteins in different fractions adds ambiguity in 
protein localization. Also, this conventional approach has several limitations: First, the cell wall 
fractions collected after cell lyses were subject to potential cytosolic contamination, even after 
extensive washing by NaCl solution of various concentrations. While some researchers (132) had 
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shown that  cytosolic components released from cell lyses didn’t  interact with cell wall fractions 
in their approach, others reported that the possibility of cytosolic contamination in the cell wall 
fractions could not be unequivocally ruled out (41) (94). Second, fractionating steps are time 
consuming. Moreover, the extraction process is often incomplete and strain dependent (73). 
Third, 2D-gel electrophoresis may not resolve glycoproteins extracted from yeast cell walls 
(142) because the same protein may have different glycoforms with different isoelectric points 
(51) and molecular weights (144), which may complicate the comparative gel based quantitative 
analysis of CWPs because of  their multiple locations in the gel. 
   
1.7 Biotinylation technique for cell surface proteome determination 
Labeling intact fungal cells by membrane impermeable biotinylating reagents is an attractive 
approach toward minimizing the influence of cytosolic contamination. The advantage of this 
method is that the biotin reagents react only with cell wall proteins (or their carbohydrate 
moiety) on or proteins adjacent to the cell surface. The labeling strategies and reagents share 
these common features including: 1. the biotin tag for affinity chromatography; 2. chemical 
groups reactive with proteins at lysine (K) or cysteine (C) residues or carbohydrate moieties of 
glycoproteins; 3. a spacer of variable length that links the biotin moiety to the protein. The strong 
affinity between avidin and biotin was first recognized in 1941 (55), but it was not until 1990 
when a biotin-avidin affinity based purification technique was introduced by Wilchek (137).  
Due to the very low dissociation constant (Kd ≈10-15 ) of the biotin-avidin complex (136), the 
captured biotinylate proteins are stable and released from avidin affinity column only under 
harsh elution conditions such as 8 M guanidine HCl. The recovery of sample is therefore often 
incomplete (117) and irreversible protein damage may occur during the elution process. This 
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problem may be partly solved either by choosing modified avidins with lower affinity such as 
nitrated avidin derivatives (96), CaptAvidin (97) and monomeric avidin (61) or using cleavable 
biotinylating reagents (e.g. Sulfo-NHS-SS-Biotin, Pierce, Rockford, IL) which allows the 
dissociation of labeled protein from the biotin-avidin complex through chemical cleavage of the 
linker (e.g. disulfide bond). The lower affinity avidins increase the recovery of biotinylated 
molecules as a result of reduced biotin-avidin binding strength, but they are also less tolerant to 
detergents, which are necessary in solubilization of membrane proteins co-precipitated with the 
cell walls. A disulfide bond linker may also be problematic because it could be susceptible to 
endogenous reduction prior to affinity purification (11). In order to increase the efficiency of 
binding between large biotinylated biomolecules and immobilized avidin, efforts were made to 
incorporate a long spacer into the labeling reagents, which would reduce the steric hindrance 
imposed by the bulky biomolecule and facilitate the docking of the biotin moiety into the avidin 
binding pocket. The most popular spacer available on the market is a monodisperse PEG 
(polyethylene glycol) based linker, which not only allows the efficient capture of the labeled 
molecule, but also prevents the aggregation of labeled protein due to the hydrophilic nature of 
the linker. It should be noted that mono-PEG spacers have an advantage over their aliphatic 
counterparts because of their lower immunogenicity in vivo (59). 
The most important part of the labeling reagent is the protein/peptide reactive moiety that 
enables biotin conjugation to proteins. An active N-hydroxysuccinimidyl (NHS) ester is the most 
commonly used functional group to modify free amine groups in proteins/peptides at pH 7.5-8.5. 
Sulfo-NHS ester is water soluble and its biotin derivatives are widely used in labeling cell 
surface proteins in vivo due to membrane impermeability of the labeling reagents (negative 
charged sulfonate group on NHS ring prevents the penetration of  sulfo-NHS-esters of biotin 
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through the plasma membrane). Other important functional groups that target cysteine residues 
are malemide and iodoacetyl moieties, which react with the free sulfhydryl group in cysteine 
residue at pH 6.5-7.5 and 7.5-8.5 respectively. It is noteworthy that the pH of the labeling 
reaction mixture needs be strictly controlled to minimize side reactions such as transformation of 
malemide by primary amines at pH above 7.5 and iodoacetyl by imidazoles at pH 5.0-7.0.  
 
Sulfosuccinimidyl-6-(biotinamido)hexanoate (sulfo-NHS-LC-biotin) and sulfosuccinimidyl-2-
(biotinamido)ethyl-1,3-dithiolpropionate (sulfo-NHS-SS-biotin) (see Figure 1.3. for their 
structures) are the most commonly used protein biotinylating reagents that react with free amines 
from the side chain of lysine residues or N-termini of proteins/peptides, and these labeling 
reagents have recently gained much popularity in studying membrane subproteome of 
mammalian cells  (22, 105, 108, 119, 122, 131), cell surface proteome of bacteria (118) (113) 
and fungi species (38, 46, 116). In the field of  C. abicans research, investigators have also 
benefited from this technique as well as the advancement in mass spectrometry instrumentation 
(4, 16) (132) (68) (89). For example, Urban and co-workers (132) employed sulfo-NHS-biotin 
labeling technique to monitor the expression of Tsa1p protein in different cell localizations. As 
mentioned earlier, the biotinylation labeling reagents are membrane impermeable due to the 
sulfonate group in sulfo-NHS-biotin molecule(125). Thus it is surprising that classic cytosolic 
and nuclear proteins were also found in of sulfo-NHS-biotin labeled protein fractions (103, 104). 
Although it is  possible that the labeling reagent may penetrates the membranes through certain 
ion channels (e.g Na+) (143) or enters freely into the aging or dead cells whose membrane 
integrity has been damaged, it is more likely that the cytosolic and nuclear proteins were non-
specifically bound to avidin during biotin-avidin based affinity chromatography (94). 
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Fortunately, such problem can be addressed by coupling the surface labeling technique with 
tandem mass spectrometry-based proteomic tools to determine the biotinylation site(s) of 
proteins. 
 
1.8 Study on dynamic change of cell surface proteome of C. albicans during the 
morphogenesis  
Conversion from the yeast form to the hyphal form has become generally recognized as a key 
virulence factor when C. albicans cells attack host cells either through epithelium invasion or 
endothelium barrier breaching (29) (82). Compared to the CWP profile of C. albicans, the 
expression change of CWPs during morphogenesis is largely unexplored. Only a few reports (37) 
(110) related to systematic comparison of cell wall proteomes of yeast and hyphal forms were 
reported. Recently, Gil and co-workers (91) conducted a comparative proteomic analysis on the 
yeast, hyphae and biofims of C. albicans. 2D-gel based approaches were employed in those 
studies but yielded limited information due to drawbacks in 2D-gel based quantification (e.g. low 
reproducibility and inaccurate measurement of gel spot volume). A two-dimentional differential 
in-gel electrophoresis (2D-DIGE ) technique (1) could be employed to improve the 
quantification of gel spot, but such approach still has the limitations inherited by all 2D-gel/MS 
based quantitative proteomic methods as discussed above(109).  
 
Stable isotopic labeling techniques, especially ICAT® (54), iTRAQ® (114), and SILAC (107) 
methods gained considerable popularity and were recently reviewed (23, 49, 102, 120). These 
labeling techniques involve both in vitro labeling via attaching isotopic tags to cysteine residues 
in protein (ICAT®)  or to free amino group in peptide (iTRAQ®) through chemical reactions,  
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and in vivo metabolic incorporation of stable isotopes into the proteins expressed by cells 
cultured in media supplemented by different isotopes (SILAC). Relative quantification is 
achieved by comparative analysis of ion intensities of peptide isotope pairs in the mass spectrum 
(ICAT®, SILAC) or by measuring the intensities of report ions derived from the labeled peptides 
in the tandem mass spectrum (iTRAQ®). The stable isotope labeling technology offers accurate 
quantification of protein accumulation levels from various sources with good reproducibility. A 
C. albicans lysine auxotrophic mutant was generated (10) that, when used along the SILAC 
technique, will allow us to monitor the CWP accumulation level changes during a yeast to hypae 
transformation of this pathogenic fungus.  
 
1.9 Development of “fluorous” affinity tag based labeling reagents  
Although biotin-avidin affinity based approaches are widely employed in the 
enrichment/separation of biological molecules, several limitations have to be considered when 
commercially available biotinylating reagents are employed to label proteins/peptides(50): 1. 
Some unlabeled proteins/peptides may nonspecifically bind to avidin (94), resulting in false 
identification; 2. The recovery of the biotinylated molecules is often low (26) (126) because of 
the high stability of biotin-avidin complex (136); 3. The biotin moiety tends to average the 
overall hydrophobicity of the tagged-peptides and compromise the separation of these peptides 
on reverse-phase liquid chromatography column(85); 4. Fragments originated from the biotin 
moiety can complicate the mass spectral interpretation of biotinylated peptides (106). 5. Biotin 
moiety may be cleaved under biotinidase catalyzed enzymatic reactions or through other even 
nonenzymatic mechanisms in vivo (12, 13). All these limitations call for the development of new 
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labeling reagents with non-biotin affinity tags for enrichment/separation of biological molecules 
including proteins/peptides.  
 
The strong non-covalent interaction between fluorinated alkyl group (fluorine-fluorine 
interactions) makes the fluorous tag one of the alternative approach to biotin labeling. (27) The 
term “fluorous” was initially coined in 1990s to denote molecules with high content of fluorine 
atoms (perfluorinated species). The perfluorinated moiety enables fluorous organic compounds 
(molecules attached by perfluorinated alkyl chain, like C8F17) to be separated from non-fluorous 
compounds by fluorous-functionalized silica gel through solid phase extraction. Non-fluorous 
compounds are first washed away by an anti-fluorous isocratic solvent, such as 60% methanol in 
water. While the affinity between fluorous moieties is strong enough to allow fluorous molecules 
to be retained on immobilized fluorous carriers after the washing, the fluorous interaction can be 
disrupted under very mild conditions. Fluorphilic solvents such as methanol and acetonitrile may 
serve to elute the fluorous fraction. Interestingly, fluorous compounds can be further fractionated 
based on the different number of fluorous tags attached to a molecule by tuning the 
fluorophilicity of the elution solvent. Molecules with higher fluorine content would be eluted 
later with more fluorophilic solvent (14) (28). 
 
The fluorous affinity technique was first introduced in fluorous biphasic catalysis technique (65) 
and soon utilized in a wide spectrum of organic syntheses (145). Recently, its application in 
enriching tagged peptides from highly complex biological mixtures was also demonstrated (14). 
The technique started to gain popularity in metabolomics (53), and microarrays for immobilizing 
small-biomolecules (101, 111). 
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CHAPTER 2 
 
 
Rapid Identification of Yeast Species and Differentiation of C. albicans Strains 
by Mass Signatures Acquired by Matrix-assisted Laser Desorption/Ionization 
Time of Flight Mass Spectrometry (MALDI-TOF-MS) 
 
2.1 Abstract 
Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) 
was used for rapid identification of yeasts, including strains of Candida albicans.  Intact yeasts 
were collected from surface colonies on agar-based media, washed in deionized water followed 
by 50% methanol, suspended in deionized water to a concentration of approximately 106 cells/ µl 
and 1 µl of each suspension was deposited into a well of a MALDI target plate.  Among several 
matrix compounds investigated, sinapinic acid crystallization worked especially well. Under 
these conditions, a sufficient number of medium size ions (4 to 15 kDa) were detectable in the 
MALDI mass spectra that could serve as “mass signatures” for unambiguous identification of the 
various yeast species and even among strains of C. albicans.  Resulting mass signatures were 
influenced by many factors, including growth medium, length of incubation and cell preparation. 
Under conditions that were optimized for the greatest number of ions with highest intensities, C. 
albicans was distinguishable from other Candida species (C. lusitaniae, C. dubliniensis, 
C.glabrata, C. rusei, C. kefyr) and from other yeast genera (Cryptococcus neoformans , 
Saccharomyces  cerevisiae and a Rhodotorula sp.). Within the species C. albicans species, 
several medium sized ions in the 5 to 10 kDa range appeared on the mass spectra of all the 
investigated strains. In addition to those shared ions, the mass spectrum of individual strains 
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contained unique ions that could be used to distinguish strains of this species. Finally, C. 
albicans germ tubes produced MALDI-TOF MS signatures that differed from yeast forms of this 
species. This is a simple, rapid and sensitive method of identifying yeasts. Identification of 
fungal molecules yielding signature mass spectra is under investigation.   
 
Keywords 
 
Mass signature, MALDI-TOF mass spectrometry, Alcohol fixation, Yeast differentiation, 
Principal component analysis 
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2.2 Introduction 
Several Candida species, and most especially C. albicans, are opportunistic pathogens that are 
among the most common causes of fungal infections. Since the advent and widespread use of the 
azole (such as fluconazole) group of antifungals which are especially inhibitory for C. albicans, 
other Candida spp. resistant to these drugs have emerged with greater frequency, notably like 
Candida glabrata (13). Although C. albicans remains the cause of the majority of cases of 
disseminated candidiasis, and with resulting high mortality rates, the increase in occurrence due 
to several other Candida spp. and their tendency for resistance against standard antifungal drugs, 
necessitates identification to the species level. Moreover other yeast genera are also important 
etiologic agents of disease and some are common contaminants in clinical and research 
laboratories (9, 20, 36, 39). Rapid identification of yeasts to the species level for clinical 
purposes, distinguishing strains within a given species for epidemiological investigations and for 
strain verification purposes in clinical and research laboratories, and monitoring yeast surface 
development in pathogenesis studies are compelling demands that continuously drive technical 
advances in the field. There are a plethora of rapid identification methods, ranging from species-
specific chromophore development on specialized media to molecular genetic approaches (37). 
Some of the methods are simple and especially applicable to the presumptive identification of C. 
albicans from other yeasts, whereas others provide at least rapid presumptive identification of 
most species and can even distinguish strains of a given species, but may be either time 
consuming and/or require considerable expertise. The approach of peptide nucleic acid-
fluorescence in situ hybridization (PNA-FISH) shows potential for rapid identification of yeast 
directly in clinical specimens (42).  A notable advantage of the PNA FISH is rapid determination 
since prior culturing of the etiologic agent is not required. Despite this impressive development 
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and other approaches cited above, a single method has not been described that is capable of 
handling all of the above applications, including strain grouping and monitoring developmentally 
expressed fungal surface characteristics. 
 
Spectroscopic approaches such as pyrolysis-mass spectrometry (Py-MS), Fourier transform-
infrared (FT-IR) spectroscopy (45), nuclear magnetic resonance (NMR) (21, 22), and Raman 
spectroscopy (25, 32) have been used for Candida species differentiation, but with mixed results 
and significant limitations. Either the spectra showed few qualitative differences between species 
(45), or the methods and analyses were too complex for practical application (46) (21, 33). In 
addition, none have shown utility for either strain grouping or for detection of developmental cell 
surface moieties. 
 
 Matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) 
is an emerging tool for microbe characterization and differentiation at the species and strain 
levels (12). Identification of microbes by MALDI-TOF MS requires a relatively small number of 
intact cells (106 -107) along with simple sample preparation procedures. Rapid data acquisition 
(in seconds) by MALDI-TOF MS and the high specificity of mass spectrometric analysis relative 
to the above mentioned techniques allows fast and accurate identification under well-defined 
conditions. Early reports focused on rapid identification of intact whole bacteria (23, 28), since 
bacteria naturally yield abundant mass spectral signals under standard conditions. These studies 
were followed by MALDI-MS identification of toxigenic and  pathogenic bacteria (10) (15, 19) 
(29, 31, 34) (41) (48, 51, 52), factors affecting spectral quality and reproducibility were defined 
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(24, 51), and automated MALDI mass spectra comparison programs were developed to facilitate 
rapid identification and speciation of intact bacteria.  
 
Studies of fungal species by MALDI-TOF mass spectrometry (1) (8, 26) (30, 47) are more 
recent, but unlike simple preparation of bacteria for analysis, investigators report the need for 
multiple sample preparation steps, such as cell wall lysis (1) in order to increase the intensities of 
diagnostic signals for species differentiation. Thus, fungi do appear to produce characteristic 
MALDI-MS signals, but the signals may be more difficult to obtain as compared to those of 
bacteria. Our first aim in this study was to optimize the MALDI-TOF MS analysis of intact yeast 
cells and then show the potential application of this technique toward identifying yeast species, 
grouping strains within a species, following developmental cell surface changes. Mathematical 
analysis of mass spectra from intact cells was also applied, which should be a useful first step in 
the development of an automated yeast identification system. 
 
2.3 Materials and Methods 
2.3.1 Yeast strains  
C. albicans strain 3153A (serotype A) was obtained from the American Type Culture Collection 
(ATCC 28367).  Strain A9 (serotype B) was originally isolated from the oral cavity of an AIDS 
patient (50) and has been used extensively in mouse-C. albicans interaction studies in our 
laboratory (16, 38).  Strain 6284 (or YJB 6284) was the result of repairing strain BWP17 to 
prototrophy (5); it has all the characteristics of a typical C. albicans, including virulence and the 
ability to germinate, thus, for the purposes of these studies, it is considered as a wild-type strain.  
Strain GPH1 is a vacuolar mutant (vps11∆) derived from YJB6284 (35). The 6284 and GPH1 
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strains were gracious gifts from Dr. G. Palmer (Louisiana State University Health Sciences 
Center, New Orleans). Other yeasts in this study included C. albicans ATCC 60193, C. glabrata 
(ATCC 15126), C. krusei (ATCC 6258), C. kefyr (ATCC 8553), Cryptococcus neoformans 
(ATCC 32045 and ATCC 66031), and Saccharomyces cerevisiae (ATCC 9763 and ATCC 
24903).  In addition, strains of Rhodotorula spp. (y2.929 and y2.196) and Candida dubliniensis 
were graciously provided by Dr. K.C. Hazen (University of Virginia Health Sciences Center, 
Charlottesville, VR).  
 
2.3.2 Culture conditions 
Unless otherwise specified, the surveyed yeast cells were stored as water stocks, and cultured on 
an agar medium containing YNB (yeast nitrogen base) (Becton, Dickinson and Company) 
supplemented with 2% glucose in Petri dishes at 22-23˚C for 4 days. In some cases, yeast cells 
were grown at 37˚C for two days or at 22-23˚C for 4 days on glucose (2%)-yeast extract (0.3%)-
peptone (1%) agar (GYEP agar).  After incubation, isolated colonies were picked to make fresh 
water suspensions for MALDI-TOF mass spectrometry analysis.  
 
The yeast form of C. albicans strain 6284 was induced to germinate (or produce hyphae) by 
nutritional and temperature shifts. After growth on GYEP agar plates at 22-23ºC for 4 days, the 
yeast cells were carefully removed, washed twice in sterile deioinized water, and inoculated at 2 
x 106 yeast forms/mL in DMEM (Dulbecco’s Modified Eagle’s Medium HEPES Modification, 
Sigma) with 2.5% fetal bovine serum followed by incubation at 37 ˚C for 2 h or for 4 h under 
aeration by rotation at 180 rpm.  Under these conditions, over 95% of the yeast cells germinated 
to become hyphal elements as determined microscopically by the formation of elongated 
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structures without evidence of constrictions at the point of emergence from the mother cell. The 
germ tubes were washed in deionized water at least twice before further treatment.  
 
2.3.3 Methanol (alcohol) fixation of fungi.  
Unless otherwise specified, the washed yeast cells were fixed by suspension in 50% 
methanol/water (v/v) (EMD Chemicals, San Diego, CA) and either analyzed immediately or 
stored at 4-6°C for up to 45 days for subsequent comparison analysis. The germ tubes were 
subjected to the same wash and fixation steps as the yeast cells. In some cases, the fungal cells 
were fixed in 80% or 100% methanol, and in 50% or 100% isopropanol (Sigma, St Louis, MO) 
using the same approach as above. 
 
2.3.4 Matrix/sample spotting method.   
Each alcohol-fixed preparation of yeast cells was suspended by vortexing and 0.5 µl of each was 
immediately transferred to wells of a 100-well gold-coated MALDI target plate (Applied 
Biosystems). Each well was immediately overlaid with 0.5 µl matrix solution. The sample-
matrix mixtures were allowed to dry at room temperature in ambient air for about 20 min. All 
sample suspensions were deposited in duplicate on the MALDI target plate.  A two-layer method 
of sample preparation (49, 53{Vorm, 1994 #181), which entailed drying the sample before 
covering it by the matrix solution, was also tested, but it provided no advantage over the 
previously described dried-droplet method (27) (data not shown). Three commonly used matrices 
were compared: α-cyano-4-hydroxycinnamic acid (CHCA, Fluka),  sinapinic acid (SA, Fluka) 
and 2,5-dihydroxybenzoic acid (DHB, Fluka). Each was freshly prepared as a saturated solution 
in 2:1 acetonitrile (EMD Chemicals) : water containing 0.1% trifluoroacetic acid (TFA, Sigma).  
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2.3.5 MALDI-TOF mass spectra acquisition   
Mass spectra were acquired on a Voyager-Elite MALDI rTOF mass spectrometer (Applied 
Biosystems, Framingham, MA) operated in the positive ion linear mode. The intensity of the 
nitrogen laser (at 337 nm) was set significantly above the threshold for desorption/ionization 
(between 2000 and 2400). The accelerating voltage was 25 kV with an extraction delay time of 
250 ns. For each sample spot (approximately 5 mm in diameter on the MALDI target plate), an 
average of 75 laser pulses were delivered at one point, and the final spectrum was the 
accumulation/average results obtained from at least 5 different points on a given same sample 
spot. Due to performance limitations of the linear mode of the MALDI-TOF mass spectrometer, 
mass assignments of ions with a mass to charge ratio (m/z) larger than 5,000 Daltons (Da) may 
bear an error of 10-20 Da.  Cytochrome C (12,362 Da), myoglobin (16,700 Da) and ubiquitin 
(8,565 Da) (Sigma, St. Louis, MO) were used as standards for external calibration.   
 
2.3.6 Principal component analysis (PCA) 
MALDI mass spectra of intact yeast cells were calibrated and processed using “Data Explorer” 
(Applied Biosystems). Some of the mass spectra were evaluated by PCA (17, 18).  After the 
spectrum baseline was corrected to zero, up to 25 of the most abundant ions in the range of m/z 
4000 – 15,000 were first selected. Among the possible 25 peaks, those with a relative intensity 
less than 5% and those with a signal/noise ratio less than 3 were discarded. The most intense 
peaks from each mass spectrum were compiled into a peak list with no redundancy. Each mass 
spectrum was compared with the compiled peak list to generate a data matrix in which the 
matched peaks (relative intensity higher than 5%, S/N larger than 3 and no more than 25 peaks) 
were denoted as 1 (100%) and the rest of the unmatched peaks were denoted as zero. PCA was 
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performed on the data matrix by using the MatLab program (The Math Works, Inc. version 7.0). 
Plotting of each spectrum was limited to the first and second principal component scores, PC1 
and PC2, respectively. 
 
2.4 Results  
2.4.1 Concentration of yeast cell suspension  
C. albicans 6284 was used as the prototypic strain to evaluate the influence of yeast cell 
concentration on the quality of mass spectra.  In preliminary experiments, water-washed yeast 
cells mixed directly with the matrix sinapinic acid (SA) matrix provided evidence that 
approximately 0.5x106 yeast cells/0.5µl was optimal for MALDI mass spectral analysis. Fewer 
satisfactory mass spectral peaks were observed at both higher and lower cell concentrations (data 
not shown).  
 
2.4.2 Effect of alcohol fixation  
Fixing the yeast cells in 50% methanol was initially employed as a killing step, but it 
surprisingly led to a significant increase in the number of ions in the MALDI mass spectrum. For 
instance, non-methanol-treated C.  albicans A9 yielded only two significant peaks between m/z 
3000 and 15000 (Figure 2.1a) as compared to a large number of peaks (more than ten) following 
methanol fixation (Figure 2.1b). Fixation treatments of 80% or 100% methanol or isopropanol 
(50% and 100%) offered no advantage over the 50% methanol fixation. Fixation had the 
additional advantage of minimizing yeast cell aggregation and, therefore, more reproducible cell 
number transfer to the target plate, as compared to the tendency for increased aggregation of 
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some strains suspended in water alone.  For the remainder of this study, 50% methanol fixation 
was used unless otherwise specified.  
 
2.4.3 MALDI matrix selection 
MALDI analyses of C. glabrata ATCC 15126 and C. albicans A9 produced different spectral 
qualities depending on the choice of matrix (Figure 2.2). When DHB was employed as the 
matrix, both C. glabrata ATCC 15126 (Figure 2.2a) and C. albicans A9 (Figure 2.2d) yielded 
poor quality mass spectra with only a few significant signals in the high mass range (m/z 5000 – 
15,000). Matrix CHCA (Figure 2.2b and 2e) worked somewhat better than DHB, but not as well 
as SA (Figure 2.2c, and 2f). SA was chosen as the most suitable matrix because it produced the 
most peaks with acceptable signal/noise ratios, and it promoted signal generation in the high-
mass range.  
 
2.4.4 Effect of incubation conditions on C. albicans mass spectra     
Examination of four C.  albicans strains grown on GYEP medium under the two conditions of 
37 °C for 2 days and 22-23 °C for 4 days showed that the influence of incubation conditions on 
MALDI mass spectra of intact yeast cells was strain dependent. For example, the mass spectra 
of C. albicans strain A9 under the two growth conditions (Figure 2.3a and 3b) did not change 
dramatically as noted by the presence of high abundant ions on both spectra, such as m/z at 
5217, 5910, 6207, 6904, 8552, and 9762. As for C. albicans 3153A, however, significant 
changes could be observed when comparing the MALDI spectra acquired under the two 
conditions (Figure 2.3c, at 22-23 °C for 4 days, and Figure 2.3d, at 37°C for 2 days). Some ions 
in the high mass range (m/z at 11341, 12279 and 13161) were evident from cells grown at 37ºC,  
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Figure 2.1. Alcohol fixation improves the quality of the MALDI mass spectrum. Candida 
albicans A9 yeast cells were prepared by either washing in deionized water (a), or washing in 
deionizied water followed by fixation in 50% methanol:water (b). Sinapinic acid was employed 
as the MALDI matrix and the concentration of the yeast cell suspensions was 106 cells/µL.  
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Figure 2.2. Three commonly used matrix compounds: 2,5-dihydroxybenzoic acid (DHB), α-
cyano-4-hydroxycinnamic acid (CHCA) and sinapinic acid (SA) were compared. MALDI 
spectra of C. glabrata ATCC 15126 were acquired in the presence of DHB (a), CHCA (b) and 
SA (c). In parallel and under the same conditions, MALDI mass spectra of C.  albicans A9 were 
acquired in the presence of DHB (d), CHCA (e), and SA (f). When SA was employed as the 
matrix, MALDI-MS produced more useful mass signatures for both C. glabrata ATCC 15126 
(c) and C. albicans A9 (f). SA was selected as the optimal matrix in the mass signature 
acquisitions of all other yeast species and strains in this study. 
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but not 22-23ºC. C. albicans strains GPH1 and 6284 also showed similar patterns of mass 
spectral changes when the spectra (not shown) of the same strain grown at the two temperatures 
and durations were compared. 
 
2.4.5 Characteristic mass spectral ions generated from C. albicans.  
The four C. albicans strains grown at 22-23˚C on GYEP agar for 4 days provided highly 
reproducible mass spectra, not only for the same strain tested at different locations on the target 
plate, but also for replicates the same strain grown under the same conditions on different days.  
Mass spectral comparisons showed a high degree of similarity between strains 3153A (Figure 
2.3a) and A9 (Figure 2.3b), and both closely matched strain 6284 (Figure 2.3e).  Mutant strain 
GPH1 however, showed significant differences from the other strains (Figure 2.3f), ions in the 
range of m/z 7000 – 8000 and above 11,000 were 
apparently not shared by the other three strains. Eight common ions at m/z 5110, 5217, 5785, 
5910, 6207, 6904, 8552 and 9762 appeared on the spectra of all four strains, which provided 
evidence that these signals might serve as signature markers for C. albicans under the employed 
conditions.  
 
2.4.6 PCA analysis of C. albicans mass spectra.  
PCA analysis was performed on the spectra of the four C. albicans strains grown under identical 
conditions except that the length and the temperature of growth were varied for comparison 
purposes. C. albicans strain 3153A incubated under two different conditions (at 22-23 °C for 4 
days and at 37 °C for 2 days) showed variation in the mass signatures (Figure 2.3c and 3d), 
which became more obvious by PCA analysis (Figure 2.4, the solid and hollow rectangle 
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symbols, respectively). The mass signatures of C. albicans strain 6284 grown under the two 
growth conditions also had noticeable differences (Figure 2.4, the solid and hollow triangle 
symbols). The mass signature of C. albicans GPH1 (Figure 2.3f) was quite different from those 
of C. albicans strains A9 (Figure 2.3a), 3153A (Figure 2.3b), and 6284 (Figure 2.3e). PCA 
analysis of these mass signatures indicated that GPH1 (the hollow circle in Figure 2.4) can be 
distinguished from the other three strains (the hollow rectangle, triangle and plus symbol in 
Figure 2.4) based on the first principle component (the x-axis in Figure 2.4). Similar mass 
signatures were grouped together on the PCA plot (Figure 2.4). GPH1 incubated under two 
conditions formed one group, whereas the other three strains (3153A, A9 and 6284) grown 22-
23 °C for 4 days formed another cluster. The latter cluster (around coordinates -1, 0 in Figure 
2.4) also included the spots (small # and + symbols that represented the mass signatures of 
strains 3153A and A9 incubated at 22-23 °C for 4 days followed by fixation in 50% methanol 
and storage at 4 °C for 45 days before mass spectrometry analysis). Storage at 4 °C for 45 days 
after fixation in 50% methanol appeared to have little effect on the mass signatures of C. 
albicans 3153A and A9. These data demonstrate that the mass signature of the same strain is 
reproducible and stable even upon relatively long-term storage.  
 
2.4.7 Differentiation of yeast species.    
A mass spectral survey on strains of various Candida species cultured on YNB-glucose agar 
medium at 22-23 ˚C for 4 days indicated that each species could be distinguished (Figure 2.5). 
The three non-Candida yeasts, C. neoformans, Rhodotorula  sp. and S.  cerevisiae also produced 
distinct mass spectral signatures that were distinguishable from the Candida species and from 
each other (Figure 2.6). C. neoformans produced ions evident at m/z 5736, 6722, 8539, 8539,  
 45
 
Figure 2.3. MALDI mass spectra were acquired for the four C. albicans strains grown on GYEP 
agar medium. Effect of growth conditions on the MALDI mass spectra is strain dependent. 
Similar MALDI mass spectra were acquired for C. albicans A9 grown at 22-23ºC for 4 days (a) 
and 37ºC for 2 days (b). Differences, especially in the high mass range, are quite obvious when 
comparing the mass spectra of C. albicans 3153A grown at 22-23ºC for 4 days (c) and grown at 
37ºC for 2 days (d). Under constant growth conditions at 22-23ºC for 4 days C. albicans strain 
GPH1 (f) could be distinguished by its MALDI mass signature from (a) C. albicans A9, (c) C. 
albicans 3153A,  and (e) C. albicans 6284.   
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Figure 2.4. Principal component analysis (PCA) of the mass signatures of C. albicans strains 
A9, 3153A, 6284, and GPH1. Each spot on the plot represents a mass spectrum. For each mass 
spectrum used in the PCA analysis, no more than 25 peaks with relative intensity higher than 
5%, S/N larger than 3 were denoted as 1 (100%) and the rest of the peaks were denoted as zero. 
PCA analysis reduced the multi-dimensional features (i.e., mass peaks denoted as 1) of each 
signature spectrum down to two principal components (PC1 and PC2). Hollow symbols: cells 
cultured at 22-23ºC for 4 days; solid symbols: cells cultured at 37ºC for 2 days. All strains were 
cultured on GYEP agar medium. The small cluster on the right includes the mass signatures of C. 
albicans GPH1 grown under two different conditions: represents the mass spectrum of 
Figure 3f. The large cluster on the left includes the mass signatures:  C. albicans  A9 
(spectrum see Figure 3a);   C. albicans 3153A (spectrum see Figure 3c):   C. albicans A9 
(spectrum see Figure 3b);   C. albicans 6284 (spectrum see Figure 3e);  # (C. albicans 
3153A) and + (C. albicans A9): cell cultured at 22-23ºC for 4 days, treated by 50% methanol 
and stored at 4ºC for 45 days before MALDI analysis.  
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8640 and 9405, all of which are shared by the two strains of this species (Figure 2.6a and 6b). 
The two strains of S. cerevisiae shared ions at m/z: 4053, 4681, 4752 and 5500 (Figure 2.6c and 
6d). Compared to other species in the survey, the two Rhodotorula sp. strains produced fewer 
peaks in their spectra (Figure 2.6e and 6f), with two shared ions at m/z 4501 and 8536. For all 
the MALDI-MS profiled yeast strains, no two strains within a given species produced identical 
spectra, and the mass spectral differences between different species were even more evident. 
 
PCA analysis of the mass signatures of C. albicans ATCC60193, C. kefyr (ATCC 8553), and C. 
neoformans (ATCC 32045 and ATCC 66031) showed that these species could be clearly 
distinguished on a PCA plot (Figure 2.7). Different strains within the same species, such as C. 
neoformans ATCC 32045 (Figure 2.6a) and ATCC 66031(Figure 2.6b), could also be 
distinguished by their mass signatures, however, usually there were fewer differences in mass 
signatures between strains within a species as compared to differences between species. 
Examples of mass signature reproducibility are offered by the close proximity of the two C. 
glabrata ATCC 15126 spots and the three spots of C. albicans ATCC 60193 on the PCA plot 
(Figure 2.7). The two mass signatures of C. glabrata ATCC 15126 were from replicate analyses 
of the same sample, while the three mass signatures of C. albicans ATCC 60193 were from three 
independent colonies. These data along with stability and reproducibility of spectra shown in the 
previous section provide evidence that MALDI-TOF mass spectral analyses are predictable 
under prescribed conditions of growth and sample preparation. 
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Figure 2.5. The MALDI mass signatures distinguish different species of Candida. When 
cultured under the same conditions (YNB with 2% glucose media at 22-23ºC for 4 days), C. 
dubliniensis (a), C. albicans ATCC 60193 (b), C. glabrata ATCC 15126 (c), C. krusei ATCC 
6258 (d) and C. kefyr ATCC 8553(e) could be distinguished by their mass signatures.   
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Figure 2.6. MALDI mass spectra can be used to differentiate between different fungal genera 
and strains within each genus. When grown under conditions similar to those used for data 
obtained in Figure 5, unique mass spectra were obtained from Cryptococcus neoformans strains 
ATCC 32045 (a) and ATCC 66031 (b), Saccharomyces cerevisice strains ATCC 9763 (c) and 
ATCC 24903 (d), Rhodotorula sp. strains y 2.929 (e) and y 2.196 (f). 
 
 
 
 
 
 50
 
 
 
 
 
Figure 2.7. The reproducibility of mass signatures was confirmed by PCA analysis. Acquired 
under identical conditions, the mass spectra (three circles) of C. albicans ATCC 60193 sampled 
from 3 different colonies on the same Petri dish were similar; nearly identical mass spectra (two 
diamonds) were also acquired for the same C. kefyr ATCC 8553 sample spotted on different 
locations of a MALDI target plate. It should also be noted that the mass spectral differences 
between yeast species (C. albicans ATCC 60193, C. kefyr ATCC 8553 and Cryptococcus 
neoformans) were greater than the mass spectral differences between strains (ATCC 32045 and 
ATCC 66031) of the same species (Cryptococcus neoformans). 
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2.4.8 Comparison of yeast and hyphal (germ tubes) forms of C. albicans   
The MALDI mass spectrum of C. albicans strain 6284 yeast forms (Figure 2.8a) was compared 
to that of the same strain germinated for 2 h (Figure 2.8b) and for 4 h (Figure 2.8c). The 
surprising finding was that the spectrum of the 4 h germination sample was rather similar to that 
of the yeast form, whereas the spectrum obtained from germination at 2 h differed significantly. 
More ions, especially in the high mass region, were generated by the 2 h germination sample 
during the MALDI process. A possible explanation is that at 4 h almost all germ tubes had 
aggregated and were difficult to suspend in 50% methanol, which caused variability of sample 
delivery to the target plate. To test this possibility, the amount of sample applied to the target 
plate was varied, but the high mass ions were consistently absent in the mass spectra (data not 
shown). The same experiment was repeated on another germination sample preparation of C. 
albicans strain 6284, and the results were consistent.  That is, several high mass ions (e.g., above 
m/z 7500) appeared on the mass spectra of 2 h germinated sample, but the higher mass ions were 
absent on the mass spectra of the 4 h old germ tubes. 
 
2.5 Discussion 
The work presented here shows the potential power of the use of MALDI-TOF mass 
spectrometry as a rapid means for yeast identification, grouping strains within a species  
and for following surface changes during a yeast-to-hyphal transition of C. albicans. Many 
parameters (e.g. the concentration of yeast suspension, type of MALDI matrix employed) 
were considered during optimization of the experiments as well as data analysis and presentation. 
The approach developed in this study should be applicable to all fungi, including molds.  
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Figure 2.8. C. albicans strain 6284 was analyzed as yeast forms (a), as 2 h old germ tubes (b), 
and as 4 h old germ tubes (c).  The mass spectra of yeast form (a) and 4 h old germ tubes (c) 
were similar, but the mass spectrum of 2 h old germ tubes (b) differed from (a) and (c).  
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In MALDI analyses, sample preparation and selection of an appropriate matrix compound are 
essential considerations in protocol development. The tight cell wall construction of fungi 
apparently limits intimate contact of the surface components with the MALDI matrix crystals, 
which results in low count ion signals and poor quality of mass signatures.  Enhancement of 
contact of surface fungal molecules with the matrix requires an optimal ratio between the matrix 
and fungal molecules (analyte); unbalanced matrix/analyte ratios lead to reduced or even total 
supression of analyte signals. Since the volume and concentration of the yeast cell suspension 
deposited onto each sample spot of the MALDI target plate was usually constant, the ratio of 
matrix:number of intact yeast cell was optimized by varying the concentration of the cell 
suspension solution. Analysis of approximately 0.5x106 yeast cells provided the best mass 
spectral result for C. albicans 6284 and other fungal cells under the conditions employed in this 
study. 
 
2.5.1 Methanol fixation of fungal cells – When analyzed by MALDI mass spectrometry, intact 
fungal cells that were washed in water prior to mixing with a matrix solution and spotting did not 
produce sufficient diagnostic ions in the range of m/z 4000 to 15,000 (Figure 2.1a), which is in 
agreement with a previous report (1). Several sample treatment methods, such as sonication (47) 
and boiling (24) (51), increased MALDI-MS signals of bacteria, however, these methods failed 
to give satisfactory results in our investigation on yeast cells (unpublished data). Since one group 
of investigators obtained improved ionization of medium sized molecules following ethanol 
fixation of whole bacterial cells (51), and as a measure of safety in the handling of potentially 
infectious organisms, we examined the effects of alcohol fixation on yeast cells. In addition to 
improving the mass spectral signals, inclusion of alcohol, such as methanol or isopropanol, in the 
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fixation buffer also facilitated suspension of the yeast cells and reproducibility in sample spotting 
onto the MALDI target plate. The novel mass spectral signals obtained following alcohol 
fixation were also reproducible as discussed below, leading to mass signature assignments. 
Compared to the cell wall lysis procedures used by others (43) (1) which may yield a larger 
number of mass spectral peaks, the alcohol fixation approach described in our work is more 
rapid, simple and it also inactivates potentially hazardous organisms.  
 
2.5.2 Yeast genera and species differentiation by mass signatures – Although the number of 
strains was small for each species studies, the results indicate that MALDI mass signatures can 
be employed to differentiate yeast cells at the genus level, as is clearly demonstrated in Figure 
2.6. The mass spectral differences between C. neoformans (Figure 2.6a and 6b), S. cerevisiae 
(Figure 2.6c and 6d), and Rhodotorula sp (Figure 2.6e and 6f) are evident by simple visual 
inspection. Differences in mass signatures can also be determined by visual examination for 
different species within the genus Candida (e.g. Candida spp in Figure 2.5). The reproducibility 
of mass spectra collected under a prescribed set of conditions allows comparisons to be made on 
spectra acquired at different times.  For example, the mass signatures of Candida spp in Figure 
2.5 can be compared with mass signatures shown in Figure 2.6, whereas the mass spectra shown 
in Figure 2.3 should not be compared to those displayed in Figure 2.5 and 6 because the yeast 
cells used for data shown in Figure 2.3 were cultured under different conditions.  
Mass signatures may be useful for the differentiation of strains within a given species, but this is 
not always the case. For example, in Figure 2.6 different strains of the same species showed 
differences in the mass signatures, and in Figure 2.3 the mass spectrum of C. albicans GPH1 
(Figure 2.3f) was quite different from the mass spectra of  C. albicans A9 (Figure 2.3a), 3153A 
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(Figure 2.3c) and 6284 (Figure 2.3e). The departure of the mutant GPH1 from other wild-type 
strains of C. albicans is of interest, because the vacuolar deficiency of GPH1 may well result in 
cell wall surface changes which may be reflected in the mass spectral signature for this strain.  
Further work is needed to determine the usefulness of mass spectral analysis of yeast mutants. 
The mass spectra of C. albicans strains A9, 3153A and 6284 were not sufficiently distinct for 
differentiation. The signatures of these strains shared a series of ions, such as m/z 5217, 5910, 
6904, 8552 and 9762 (Figure 2.3); these ions can be used to group the three strains. A greater 
number of strains need to be surveyed in order to gain a more thorough appreciation of the power 
of the mass signatures approach in grouping strains, and possibly mutants, within a given 
species. 
 
2.5.3 Reproducibility of mass signatures under well defined conditions - Rapid yeast 
identification by MALDI-MS is an attractive approach because of its simplicity and potential for 
high throughput analyses. Although the production of diagnostic signals in MALDI mass spectra 
is the key to the approach, reproducibility of the signals is critical. In our work, the spectra were 
highly reproducible provided that the organisms were grown and fixed under a common set of 
conditions. In general, alcohol fixation worked well, but 50% methanol fixation consistently 
yielded a sufficient number of diagnostic signals that could be used to constitute a mass signature 
for a given species. Other important parameters that could affect mass signature reproducibility 
included the number of yeast cells placed in the MALDI sample spot, choice of matrix 
compound, sample spotting technique, and cell incubation conditions. For example, yeast cells, 
such as C. albicans strain A9, grown at 37 ºC for 2 days (Figure 2.3a) yielded essentially the 
same mass signature as when grown at 22-23 ºC  for 4 days (Figure 2.3b); but for other yeast 
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cells, such for C. albicans strain 3153A, the mass signatures (Figure 2.3c and 3d) varied 
somewhat depending on the temperature and length of growth. In the latter example, even though 
there were obvious changes in some of the characteristic signals, several diagnostic peaks were 
recorded regardless of growth temperature (e.g. m/z 6904, 8552, 9762). For identification and 
differentiation purposes, the MALDI mass signatures of yeast cells should be acquired from 
fungal cells grown and prepared under the same conditions so as to minimize variations in the 
mass signature of a given strain.  
 
Under the same conditions of growth and sample preparation, our findings concerning the 
reproducibility of mass signatures is consistent with other results reported on MALDI-TOF 
analysis of bacterial cells (2, 40). In addition, we found that fungal cells could be stored prior to 
mass analysis without significantly affecting the results.  For example, the mass signature 
acquired for C. albicans strain A9 incubated at 22-23 ˚C in GYEP for 4 days and immediately 
treated with 50% methanol followed promptly by MALDI-TOF mass spectrometry analysis 
provided essentially identical signals as when the same strain was grown under identical 
conditions except that it was stored for 45 days at 4 ˚C before methanol fixation and mass 
analysis. The two mass signatures (spots: + and  in Figure 2.4) can be clustered together as 
revealed by PCA analysis. Mass signatures were also consistent for the same yeast strain 
deposited on different sample spots on the same MALDI target plate, as well as on different 
sample spots on different MALDI target plates (See Figure 2.7, duplicate analysis of C. kefyr 
ATCC 8553), and for separate colonies grown in different areas of the same Petri dish (See 
Figure 2.7, the three C. albicans ATCC 60193 spots). 
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2.5.4 PCA analysis of mass signatures – As indicated above, diagnostic signals are consistent 
under a prescribed set of conditions, but the relative peak intensities of a given ion signal may 
vary from spectrum to spectrum. To minimize this variability for PCA analysis we degenerated 
the relative intensities of diagnostic peaks to zero and 100%, thus leaving the presence of 
diagnostic peaks as the only characteristic feature.  This simplified approach was effective in 
clustering the mass signatures of the same yeast strain, even when the data were acquired from 
yeast prepared under slightly different conditions. As shown in Figure 2.4, the spot that 
represents the mass signature of C. albicans 3153A grown at 22 ºC for 4 days (  ) can be 
clustered with the same strain grown under the same conditions but stored for 45 days (#). 
Importantly, this PCA analysis approach is an effective tool in clustering intact yeast cell mass 
signatures even without prior information, such as the genotype and phenotype of a given yeast 
of interest. Thus, PCA employed as a mass signature clustering tool has the potential of playing 
an important role in both small and large scale yeast identification.   
 
2.5.5 Origin of the diagnostic signals - Analyte molecules that are in physical contact with the 
matrix molecules are those that can be desorbed/ionized leading to their detection and display in 
mass spectra. Since the matrix molecules are not capable of penetrating the cell wall, the medium 
sized molecules (4000-15000 Da) detected in our work most likely originate from the yeast cell 
surface. One possible explanation for the increased signals following alcohol fixation is that cell 
surface macromolecules unfold, thus exposing medium size molecules (4000 to 15000 Da) to the 
matrix. A second possibility is that the fixation may have promoted release of cell membrane or 
cytosolic materials to the cell surface and contact with the matrix. The yeast cell wall 
biopolymers are comprised of proteins and polysaccharides (7). Since MALDI-MS ionization 
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conditions in the linear mode preserve even weak non-covalent hydrogen bonds (11) (6, 44), it is 
unlikely that covalent bonds of the large biopolymers would be cleaved to yield fragments 
smaller than 15 kDa. Given the flux and energy of the UV laser employed in our experiments, 
we cannot, however, totally rule out the possibility that certain weaker covalently bound cell 
surface biopolymers might be cleaved and yield ions in the range of m/z 4000 – 15,000. 
 
Sinapinic acid is a well described MALDI matrix compound that is especially useful for the 
analyses of peptides and small proteins (3, 4). In our study, this matrix worked the best among all 
those tested for analyses of the intact yeast cells (Figure 2.2), which is consistent with another 
report (19), and this suggests that the detected ionized yeast cell surface molecules may well be 
proteins/peptides, or molecules with amino acid residues. In addition, in this study we employed 
the “dried droplet” method in MALDI sample spotting, which favors ionization of proteins and 
peptides (14). The polysaccharides that are abundant on the yeast cell surface would require a 
different matrix compound and sample spotting method for efficient ionization (6), (14). 
 
2.5.6 Monitoring the mass signatures of C. albicans at different morphological states - C. 
albicans typically undergoes morphogenesis upon tissue invasion, resulting in the formation of 
several fungal forms, including yeast (blastospores or blastoconidia) , hyphae (germ tubes or 
mycelia) and pseudohyphae. We found that each morphogenetic form of C. albicans (wild type 
strain 6284) is characterized by a unique mass signature (Figure 2.8). It should be noted that the 
2 h germinated C. albicans (pseudohyphae) yielded the most ions in the range of m/z 4000 – 
15,000, which implies that changes in the pseudohyphal cell wall may promote the release of 
more mid-size molecules (Figure 8b). The results for the 4 h germ tubes were surprising in that 
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they differed from the 2 h germ tubes, and, instead, appeared more like yeast forms.  The noted 
difficulty in spotting due to aggregation of 4 h germ tubes may have resulted in clumps of 
hyphae directed away from contact with the matrix, exposing mostly the mother yeast cells. 
Alternatively, by 4 h the hyphal cells may be in transition back to the yeast form. These 
explanations are currently under investigation. Regardless of the explanation, unique signals 
were obtainable during the transition of yeast to hyphal forms. Identification of these unique 
signals is the subject of current studies. 
 
2.6 Concluding remarks 
In this study, we demonstrated that the MALDI-TOF mass spectra of intact yeast cells can 
provide mass signatures for identification of fungal cells at the genus and species levels. If 
appropriately fixed before analysis, intact yeast cells will produce mass signatures just as readily 
as those produced by bacteria without prior any treatment. Mass signatures could also be 
employed to differentiate strains within a genus, or at least group together yeast strains in case 
where difference between individuals was not remarkable. The identification process is rapid, 
and requires a tiny amount of sample (106 -107 intact cells). Fixation of the pathogenic yeast with 
50% methanol in water greatly improves the quality of the MALDI mass spectra in terms of 
increasing the number of characteristic ions with better signal-to-noise ratios. Aided by 
mathematical tools such as principal component analysis, the creation of MALDI mass signature 
libraries will serve as an effective tool for fast identification of intact yeast cells in clinical and 
research laboratories. 
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CHAPTER 3 
 
Synthesis and Applications of “Fluorous” (Fluorinated Alkyl) Affinity 
Reagents That Label Primary Amine Groups in Proteins/Peptides 
 
3.1 Abstract 
Strong non-covalent interactions such as biotin-avidin affinity are commonly utilized in 
protein/peptide enrichment/separation. A new type of “fluorous” (fluorinated alkane) affinity 
gained popularity due to its low level non-specific binding to proteins/peptides. We developed 
two generations of fluorous labeling reagents which were reactive toward primary amine groups 
in proteins/peptides. The 2nd generation reagents were highly water soluble and the labeling 
reactions with proteins/peptides could proceed in an aqueous environment. The acid labile linker 
in the labeling reagent allows cleavage of the bulky fluorous tag moiety and the long oligo 
ethylene glycol (OEG) spacer after fluorous affinity purification. Upon collision induced 
decomposition, the labeled peptide ion yielded a characteristic fragment that could be retrieved 
from the residual portion of fluorous affinity tag, and served as a marker to indicate that the 
relevant peptide had been successfully labeled. Analysis of results showed that both the labeling 
and affinity enrichment/separation process were highly efficient.  
 
 
 
 
 65
3.2 Introduction 
Proteins and peptides in living organisms accumulate at different levels with wide dynamic 
range.  It is usually necessary to enrich and/or purify native proteins and peptides for further 
characterization. Given the complexity of biological samples, extraction and fractionation of 
proteins/peptides of interest can be challenging.  
Conjugating an affinity tag to protein/peptide is an attractive approach in protein/peptide 
enrichment and purification. Certain functional groups, such as a thiol group from cysteine(7), an 
amine group from lysine (20) (12) and a phenol group from tyrosine (10) could serve as direct 
targets for conjugation. A few other functional groups from post modifications, such as 
phosphoserine and phosphothreonine were suitable to be converted to thiol first, and then 
conjugated with an affinity tag (1, 14).Biotin is almost exclusively chosen as the affinity tag 
moiety in conjugating reagents due to the biotin-avidin interaction, which is one of the strongest 
non-covalent interactions in nature with a dissociation constant (Kd) of 10-15 (21). For affinity 
purification purpose, this well-known biotin-avidin interaction also has several limitations: 1. 
Some proteins/peptides may nonspecifically bind to avidin (11); 2. Low recovery of the biotin-
tagged molecules in affinity purification is common because of the incomplete elution of 
biotinylated molecules from avidin resins (4) (19); 3. The biotin moiety tends to average the 
overall hydrophobicity of the tagged-peptides and compromise the separation of these peptides 
on reverse-phased liquid chromatography column (9); 4. Fragments originated from biotin 
moiety can complicate the mass spectral interpretation of biotin tagged peptides (14). 
Incorporation of cleavable linker between the biotin moiety and the peptide reactive group 
allows the removal of biotin moiety, and this approach has been employed in cleavable ICAT 
reagents (9, 22) that targets the free thiol group in proteins/peptides.  
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The fluorine-fluorine interaction (“fluorous affinity”) based binding and separation was first 
demonstrated in fluorous biphasic catalysis technique (8). Since then the fluorous affinity 
method has been successfully utilized in a wide spectrum of organic syntheses (23).  Recently, 
its application was introduced to proteomics (3), metabolomics (6), and microarrays for 
immobilizing small-biomolecules (17) (13, 16). The flourous affinity is characterized by the 
strong non-covalent interactions between the fluorous affinity tag (which can be conjugated to 
molecules of interest) and fluorous resin. The interactions between fluorous resin and 
proteins/peptides are generally weak, the non-specific binding of protein/peptides to the fluorous 
resin, if any, can be easily disrupted. Moreover, fluorous affinity based separation technique 
allows fractionation of the same molecules with different number of fluorous tags (3). Similar 
phenomenon can not be found in biotin-avidin based separation approaches.  
  
Unlike the biotin group, which is quite small (244 Da), the fluorous tags are usually quite large 
with 448 Da for a commonly used tag C8F17CH2CH3. The strength of fluorous affinity increases 
with the number of fluorine in the fluorous tag (5). Moreover, fluorous compounds are general 
water insoluble due to the very strong hydrophobicity of fluorous tag. This main caveat limits its 
application in biological system where physiological environment need be maintained (e.g. in 
PBS buffer) and may cause protein aggregation from multiple “post-modifications” by fluorous 
tags. Also, the bulky fluorous affinity tag complicates the fragmentation pattern of tagged 
peptides and makes it more difficult to interpret the tandem mass spectra of tagged peptides. 
Incorporation of a polar, hydrophilic spacer between the fluorinated alkyl moiety and the reactive 
group will increase the solubility of the reagent and labeled protein, however, the fragmentation 
pattern of the tagged peptides will be complicated by the fragment ions from the spacer.  
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Therefore, it is necessary to remove the fluorous tag and spacer from the labeled molecule before 
LC-MS analysis.  
 
In this study, we developed two generations of fluorous reagents (1st generation fluorous labeling 
compound: Boc-pentanoic-NHS-perfluoroctane (FBPNHS) (Figure 3.1 A ) and 2nd generation 
compounds including two analogues: sulfo-NHS-(OEG)3-perfluoroctane (FP3CMSNHS), sulfo-
NHS-(OEG)1-perfluoroctane (FP1CMSNHS) (Figure 3.1 B and C) which both could label free 
amines from peptides and proteins.  Compared to our 1st generation labeling reagent (FBPNHS), 
which is not water soluble, the 2nd generation molecules are novel water soluble fluorous 
labeling reagents that included a protein/peptide reactive group (Sulfo-N-Hydroxylsuccinimidyl 
ester, Sulfo-NHS) (18), an acid labile linker (a tertiary carbomate group), an oligoethylene glycol 
(OEG)3 spacer and a perfluorinated alkane moiety (C8F17). Labeling protein/peptides with our 
synthesized flourous labeling reagents (A and C in Figure 3.1) was demonstrated along with the 
purification/separation and LC-MS analysis of the tagged protein/peptide. 
 
3.3 Materials and Methods 
Fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu), LiALH4, pyridine, N,N- 
tertrabutylammonium fluoride (TBAF), trifluoroacetic acid (TFA), ammonium formate, bovine 
serum albumin (BSA), DL-dithiothreitol (DTT), iodoacetamide (IA) and 5-aminovaleric acid 
were purchased from Sigma (St. Louis, MO). 2-{2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}-
ethanol and [N- (ε –maleimidocaproyloxy) sulfosuccinimide ester] (Sulfo-EMCS) were 
purchased from Molecular Bioscience, Inc (Boulder, CO).  
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N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCI) (Advanced ChemTech, 
Louisville, KY).  1-hydroxybenzotriazole, anhydrous (HOBt) was purchased from Chem-Impex 
International, Inc.(Wood Dale, IL). N,N′-disuccinimidyl carbonate (DSC), 1-Boc-piperazine 
(Oakwood Products, Inc., West Columbia, SC), tetrabutylammonium fluoride (TBAF,) and 
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) were purchased from EMD 
Chemicals Inc. (Gibbstown, NJ). Diisopropylethylamine (DiPEA), and p-nitrophenylchloromate 
were purchased from Acros (Raritan, New Jersey). ACTH (4-11) was purchased from American 
Peptide Company, Inc. (Sunnyvale, CA). Sequencing grade modified trypsin was purchased 
from Promega, Inc (Madison, WI). Fluorous silica gel (5 µm in diameter), 2H,2H,3H,3H-
perfluoroundecanoic acid and 2-[2-(1H,1H,2H,2H-perfluorohexyl) 
isopropoxycarbonyloxyimino]-2-phenylacetonitrile (F-BOC-ON) were purchased from Fluorous 
Technologies Inc (Pittsburg, PA). 
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Figure 3.1. Structures of synthesized fluorous labeling reagents A, B and C. 
 
 
 
 
 
 
 
 
 
 70
3.4 Experimentals 
3.4.1 Synthesis of fluorous labeing reagent (FBPNHS) (Scheme 3.1) 
5-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-1,1-dimethyl-
undecyloxycarbonylamino)-pentanoic acid (1’) 
90.7 mg (0.77 mM, 1.05 eq) of 5-amino-pentanoic acid was taken up in 1.5 mL of 
dichloromethane and 315 µL of diisopropylethylamine (2.5 eq) was added. 
The stirred mixture was then cooled to 0° C in an ice bath.  To this mixture was added 110 µL of 
trimethylsilylchloride (0.87 mM, 1.2 eq) under nitrogen and the reaction was allowed to proceed 
for 10 minutes. Then a solution of F-BOC-ON (500 mg, 0.73 mM, 1.0 eq) in 2 mL THF was 
slowly added to the flask. The ice bath was removed to let the reaction continue for 10 hours at 
room temperature. The reaction was quenched with 2mL of 2N HCl and extracted into ether 2-3 
times. The organic layers are combined, dried over magnesium sulfate, followed by solvents 
evaporation. The extracted product was purified by silica gel column chromatography with ethyl 
acetate-hexane 1:3 as the elution solvent. Purified product 2 (464 mg, 98%) was obtained as 
white solid 1’.  1H NMR (400 MHz, DMSO-d6) δ 1.34 (t, J=7.0 Hz, 2H), δ 1.38 (s, 6H), 1.44 (t, 
J=7.0 Hz, 2H), 1.94 (t, J=7.0 Hz, 2H),  2.16 (t, J= 7.0 Hz, 4H), 2.88 (q, J=6.2 Hz ,2H), 6.94 (t, 
J=5.1 Hz, 1H), 11.96 (s, 1H). ESI-MS: (M+H)+ =650.1. 
 
1.2 5-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-1,1-dimethyl-
undecyloxycarbonylamino)-pentanoic acid 2,6-dioxo-piperidin-1-yl ester (FBPNHS) (2’’) 
To a stirred solution of 2 (200 mg, 0.31 mM, 1.0 eq) was dissolved in 2mL anhydrous DMF, to 
which DSC ( 158 mg, 0.62 mM, 2.0 eq) and pyridine ( 73 mg, 0.93 mM, 3.0 eq) were added. The 
mixture was stirred overnight at room temperature and solvent was  
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removed under vacuum. Crude product was purified by silica gel column with ethyl acetate-
hexane 2:1 as the elution  solvent to give the pure product 3 (188 mg, 80%) as white solid 2’’. 1H 
NMR (400 MHz, CDCl3) δ 1.48 (s, 6H), 1.59 (q, J=7.0 Hz, 2H),  1.75 (q, J=7.0 Hz, 2H), 2.12 
(m, 2H), 2.75 (m, 6H), 3.15 (t, J=7.0 Hz, 2H), 4.80 (s, 1H). ESI-MS: (M+H)+ =761.1. 
 
3.4.2 Labeling small peptides MRFA and ACTH (4-11) using FBPNHS 
To avoid rapid hydrolysis of the compound, excessive amount of peptide was used in this study. 
10µL of 153 mM MRFA aqueous solution was mixed with 50 µL of 2.5 mM FBPNHS THF 
solution. The reaction proceeded at room temperature for one hour. 0.5 µL of mixture was 
diluted in 60 µL of ethanol containing 5% FA and analyzed on the mass spectrometer through 
direct infusion.  
 
Longer peptides ACTH (4-11) were dissolved in DMF : NaHCO3 (50 mM in water)  = 3: 1 (v/v, 
pH=7.8).  9 µL of 50 mM ACTH (4-11) was mixed 20 µL of 50 mM FBPNHS in THF solution. 
The mixture was set at room temperature for 1hour, followed by addition of 2 µL of 100 mM 
Tris (in THF/H2O ,vol/vol=1/1) and mixing for 30 minutes at room temperature. The products 
were dried under vacuum, and the fluorous tag was cleaved in 100 µL of ICAT cleavage reagents 
according to the procedures described in the manufacture’s protocol (Applied Biosystems). After 
1 hour, an aliquot of 1 µL solution was diluted to 100 µL of 50% MeOH for immediate ESI-MS 
analysis.  
 
3.4.3 Labeling a standard protein bovine serum albumin (BSA) using FBPNHS 
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BSA (~0.7 nM, 20 µL) (Sigma-Aldrich, St Louis, MO) in the same solvents used in the peptide 
labeling above was reacted with 15 µL of FBPNHS (1.5 µM) in THF solution with mixing at 
room temperature. The reaction was allowed to proceed for 1 hour and quenched by adding 5µL 
of 5 M Tris and mixing for 20 minutes. After solvents evaporation, 200 µL of the ICAT cleavage 
reagents was added. The cleavage reaction was allowed to proceed for 2 hours at 37°C. After the 
completion of the cleavage, solvents were evaporated, and the labeled BSA was re-dissolved in 
50% MeOH and separated from excessive labeling reagents, which became insoluble in 50% 
MeOH. The labeled BSA was vacuum dried and dissolved in 50 mM ammonium bicarbonate for 
alkylation and trypsin digestion. Digested tryptic peptides were analyzed by LC-MS and by 
database search as described below. 
 
3.4.4 Synthesis of Sulfo-NHS-(OEG)3-perfluoroctane ( Scheme 3.2 to Scheme 3.5 ) 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-(2-(2-(2-(2-
hydroxyethoxy)ethoxy)ethoxy)ethyl)undecanamide (1) 
EDCI (0.64 g, 3.3 mM, 1.1 eq) and HOBt (0.68 g, 4.5 mM, 1.5 eq) was added to a stirred 
mixture of 2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethanol (0.62 g, 3.2 mM, 1.05 eq) and 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanoic acid (1.50 g, 3.0 mM, 1.0 eq.) 
in 20 mL anhydrous dichloromethane (CH2Cl2) at room temperature. After 16 hr stirring, the 
solution was diluted by CH2Cl2, washed by saturated sodium bicarbonate, extracted by CH2Cl2. 
Combined organic layer was washed by brine, dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by flash column chromatography (SiO2, eluent: 
9:1 CH2Cl2/MeOH) as pale brown oil 1 (1.56 g, yield: 78%). 1H NMR (400 MHz, CDCl3) δ 2.49 
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(m, 2H), 2.58 (m, 2H), 3.49 (t, J=5.0 Hz, 2H), 3.56 (t, J=5.1 Hz, 2H), 3.67 (m, 4H), 3.71 (m, 4H), 
3.81 (t, J=6.0 Hz, 2H), 4.45 (t, J=6.0 Hz, 2H), 6.26 (s, 1H). ESI-MS: (M+H)+ =668.1. 
 
16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,23-heptadecafluoro-13-oxo-3,6,9-trioxa-12-
azatricosyl 4-nitrobenzoate (2) 
4-nitrophenyl chlorofomate (0.72 g, 3.6 mM, 1.5 eq.) in 5mL anhydrous CH2Cl2 was slowly 
added to a solution of c (1.4 g, 2.4 mM, 1.0 eq.) and  DiPEA (0.93g, 7.2 mM, 3.0 eq.) in 15 mL 
anhydrous CH2Cl2 at 4°C. The mixture was stirred for 16 hr while gradually warmed to the room 
temperature. The reaction was quenched by adding ice-cold 0.5N HCl, extracted by CH2Cl2. 
Organic layer was washed by H2O, brine, dried over MgSO4 and concentrated in vacuo. The 
crude product was purified by flash column chromatography (SiO2, eluent: 1:1 
hexane/ethylacetate) as pale yellow waxy solid 2 (1.80 g, yield: 90%). 1H NMR (400 MHz, 
CDCl3) δ 2.46 (m, 2H), 2.49 (m, 2H), 3.47 (t, J=5.0 Hz, 2H), 3.57 (t, J=5.0 Hz, 2H), 3.65 (m, 
4H), 3.70 (m, 4H), 3.81 (t, J=6.0 Hz, 2H), 4.44 (t, J=6.0 Hz, 2H), 6.25 (s, 1H), 7.38 (d, J=9.2 Hz, 
2H), 8.28 (d, J=9.2 Hz, 2H). ESI-MS: (M+H)+ =817.1 
 
4-amino-2-methyl-butan-2-ol (3) 
To a vigorously stirred solution of LiAlH4 (2.8 g, 74 mM, 5.0 eq.) in 140 mL ice-cold dry ether 
was slowly added 2-methylpent-4-yn-2-ol (1.45 g, 14.8 mM, 1.0 eqiv.) in 50 mL dry ether. After 
stirring for 1 hour at room temperature, the mixture was refluxed for 10 hours. After cooling, 15 
mL ice cold 10% NaOH was slowly added to the reaction under stirring to quench the reaction. 
After additional 2 hour stirring, precipitates were filtered and washed thoroughly by 70 mL THF 
three times. After removal of THF in vacuo, 80 mL of 15% NaOH was added to the residue 
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followed by extraction of 90 mL DCM three times. Organic phase was combined, washed by 
brine and dried over MgSO4 overnight. Solvents were evaporated to afford product as pale 
yellow oil 3 (1.40g, yield: 92%), which was used for the next step without further purification. 
 
(3-Hydroxy-3-methyl-butyl)-carbamic acid 9H-fluoren-9-ylmethyl ester (4) 
Compound 3 (0.60 g, 5.8 mM, 1.0 eq ) was taken up in 20 mL 5% Na2CO3 and cooled off in an 
ice-water slurry bath. Fmoc-Osu (2.16 g, 6.4 mM, 1.1 eq) in 25 mL THF was slowly added to the 
mixture. After stirring for 16 hr, THF was removed in vacuo and the aqueous phase was 
extracted by 70 mL DCM three times. The extracts were combined, washed by brine, dried over 
MgSO4 and evaporated to dryness. Crude product was purified by flash column chromatography 
(SiO2, eluent: 6:1 DCM/ethylacetate) as white solid 4 (1.75g, yield: 93 %). 1H NMR (400 MHz, 
CDCl3) δ 1.27 (s, 6H), 1.71 (t, J=6.8 Hz, 2H), 3.64 (t, J=6.8 Hz, 2H), 4.22 (t, J=6.8 Hz, 1H), 4.38 
(d, J=6.8 Hz, 2H), 5.37 (s, 1H), 7.31 (t, J=7.2 Hz, 2H), 7.40 (t, J=7.2 Hz, 2H), 7.60 (d, J=7.2 Hz, 
2H), 7.76(d, J=7.2 Hz, 2H). ESI-MS: (M+H)+ =326.2 
 
Carbonic acid 3-(9H-fluoren-9-ylmethoxycarbonylamino)-1,1-dimethyl-propyl ester 4-
nitro-phenyl ester (5) 
To a solution of 4 (0.76 g, 2.3 mM, 1.0 eq) and pyridine (5 mL) in 25 mL DCM was slowly 
added 4-nitrophenyl chlorofomate (0.94 g, 4.6 mM, 2.0 eq) in 9 mL DCM at 0°C. The mixture 
was stirred for 8 hours at room temperature and poured into 90 mL 0.5 N cold HCl. 300 mL 
DCM was used for 3 times of extraction and the extracts were washed by brine, dried over 
MgSO4 before evaporated to dryness. Crude product was purified by flash column 
chromatography (SiO2, eluent: 5:1 hexane/ethylacetate) as colorless to light yellow oil 5 (1.10 g, 
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yield: 96%). 1H NMR (400 MHz, CDCl3) δ 1.60 (s, 6H), 2.07 (t, J=7.6 Hz, 2H), 3.40 (t, J=7.6 
Hz, 2H), 4.22 (t, J=6.8 Hz, 1H), 4.42 (d, J=6.8 Hz, 2H), 4.93 (s, 1H), 7.28 (t, J=7.2 Hz, 2H), 7.23 
(t, J=7.2 Hz, 2H), 7.35 (d, J=8.4 Hz, 2H), 7.40 (t, J=7.2 Hz, 2H), 7.58 (d, J=7.2 Hz, 2H), 7.76 (d, 
J=7.2 Hz, 2H), 8.24 (d, J=8.4 Hz, 2H). ESI-MS: (M+H)+ =491.2 
 
Bis(2,5-dioxopyrrolidin-1-yl) 3,3'-disulfanediyldipropanoate (6) 
To a solution of 3,3'-disulfanediyldipropanoic acid (50 mg, 0.24 mM, 1.0 eq) and pyridine (0.11 
mL, 6.0 eq) in 3mL DCM was added DSC (182 mg, 0.72 mM, 3.0 eq). The mixture was stirred 
for at room temperature overnight then diluted by 10 mL DCM before poured into 10 mL 0.2 N 
cold HCl. Additional 50 mL DCM was used for extractions and the extracts were washed by 
brine, dried over MgSO4 before evaporated to dryness. Crude product was purified by flash 
column chromatography (SiO2, eluent: 2:3 hexane/ethylacetate) as white solid 6 (89 mg, yield 
93%). ESI-MS: (M+H)+ =405.53 
 
Di-tert-butyl 4,4'-(3,3'-disulfanediylbis(propanoyl))bis(piperazine-1-carboxylate) (7) 
To a solution of 6 (0.5 g, 1.23 mM, 1.0 eq) and DiEA (0.47 mL) in 11 mL DCM was slowly 
added tert-butyl piperazine-1-carboxylate (0.51 g, 2.72 mM, 2.2 eq) in 5 mL DCM at room 
temperature. After 3 hours stirring, solvents were evaporated and crude product was recrystalized 
by hexane/ethylacetate as white solid 7 (0.62 g, yield: 94%). 1H NMR (400 MHz, CDCl3) δ 1.47 
(s, 18H), 2.76 (t, J=6.8 Hz, 4H), 2.97 (t, J=6.8 Hz, 4H), 3.46 (m, 8H), 3.48 (t, J=4.9 Hz, 4H), 
3.60 (t, J=4.9 Hz, 4H).  ESI-MS: (M+H)+ =546.4 
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Bis(4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylbutan-2-yl) 4,4'-(3,3'-
disulfanediylbis(propanoyl))bis(piperazine-1-carboxylate) (8) 
Compound 7 (0.5 g, 0.91 mM, 1.0 eq.) was taken up by 2.5 mL of 50% TFA in DCM under 
stirring at room temperature. After 1 hour cleavage reaction, solvents were evaporated under 
reduced pressure and the resulting residue was mixed with 6 mL DCM, 1.7 mL DiEA and HOBt 
(27.6 mg, 0.20 eq). To this mixture was added compound 5 (0.98 g, 2.0 mM, 2.2 eq) in 5 mL 
DCM. After stirring for 16 hours, 30 mL of 0.5 N cold HCl was added to quench the reaction and 
200 mL DCM was then used for 3 times of extractions. The extracts were washed by brine, dried 
by MgSO4 and evaporated to dryness. Crude product was purified by flash column 
chromatography (SiO2, eluent: ethylacetate) as white solid 8 (0.7 g, yield: 73%). 1H NMR (400 
MHz, CDCl3) δ 1.49 (s, 12H), 2.30 (t, J=6.8 Hz, 4H), 2.74 (t, J=7.0 Hz, 4H), 2.95 (t, J=7.0 Hz, 
4H), 3.28 (t, J=6.8 Hz, 4H), 3.41 (m, 4H), 3.44 (m, 8H), 3.57 (m, 4H), 4.20 (t, J=6.4 Hz, 2H), 
4.40 (d, J=6.4 Hz, 4H), 4.80 (s, 2H), 7.31 (t, J=7.6 Hz, 4H), 7.40 (t, J=7.6 Hz, 4H), 7.58 (d, J=7.6 
Hz, 4H), 7.62 (d, J=7.6 Hz, 4H).  ESI-MS: (M+H)+ =1049.4 
 
23,23,24,24,25,25,26,26,27,27,28,28,29,29,30,30,30-heptadecafluoro-2-methyl-6,20-dioxo-
7,10,13,16-tetraoxa-5,19-diazatriacontan-2-yl 4-(3-((3-(4-
(24,24,25,25,26,26,27,27,28,28,29,29,30,30,31,31,31-heptadecafluoro-3,3-dimethyl-7,21-
dioxo-2,8,11,14,17-pentaoxa-6,20-diazahentriacontan-1-oyl)piperazin-1-yl)-3-
oxopropyl)disulfanyl)propanoyl)piperazine-1-carboxylate (9 ) 
To a solution of 8 in 0.7 mL anhydrous DMF was added 66 mg TBAF. After 2 hours, TLC 
showed complete de-protection and compound 2 (135 mg, 0.16 mM, 2.0 eqiv.) in 4 mL 
anhydrous DCM was slowly added at room temperature, followed by addition of DiEA (0.03 
 78
mL). The mixture was stirred overnight, and then the reaction was quenched by adding 10 mL 
ice cold 0.2 N HCl. The separated aqueous phase was further extracted by 60 mL DCM 3 times. 
The extracts were washed by brine, dried by MgSO4 and evaporated to dryness. Crude product 
was purified by flash column chromatography (SiO2, eluent: 13:1 DCM: MeOH) as pale oil 9 
(135 mg, yield: 84 %). 1H NMR (400 MHz, CDCl3) δ 1.47 (s, 12H), 2.00 (t, J=7.2 Hz, 4H), 2.47 
(m, 4H), 2.51 (m, 4H), 2.76 (t, J=7.1 Hz, 4H), 2.95 (t, J=7.0 Hz, 4H), 3.25 (q, J=7.2 Hz, 4H), 
3.40 (m, 16H), 3.56 (t, J=5.0 Hz, 4H), 3.60 (m, 24H), 4.19 (t, J=5.0 Hz, 4H), 4.99 (s, 2H), 6.63 
(s, 2H). ESI-MS: (M+H)+ =1991.5 
 
23,23,24,24,25,25,26,26,27,27,28,28,29,29,30,30,30-heptadecafluoro-2-methyl-6,20-dioxo-
7,10,13,16-tetraoxa-5,19-diazatriacontan-2-yl 4-(3- mercaptopropanoyl)piperazine -1-
carboxylate (10) 
0.6 mL of  TCEP.HCl (65 mg, 0.23 mM, 4.0 eq ) in saturated NaHCO3 was added to 3 mL THF 
solution of  compound 9 (113 mg, 0.057 mM, 1.0 eq). After stirring for 9 hours, solvents were 
evaporated under reduced pressure. The crude product was purified by flash column 
chromatography (SiO2, eluent: 20:1 DCM: MeOH) as pale brown oil 10 (52 mg, yield: 93%). 1H 
NMR (400 MHz, CDCl3) δ 1.47 (s, 6H), 1.73 (t, J=8.0 Hz, 1H), 2.00 (t, J=7.2 Hz, 2H), 2.49 (m, 
2H), 2.52 (m, 2H), 2.65 (t, J=6.8 Hz, 2H), 2.81 (q, J=7.2 Hz, 2H), 3.24 (q, J=7.2 Hz, 2H), 3.40 
(m, 8H), 3.56 (t, J=5.2 Hz, 2H), 3.63 (m, 12H), 4.19 (t, J=5.2 Hz, 2H), 4.99 (s, 1H), 6.63 (s, 1H). 
ESI-MS: (M+H)+ =997.3 
 
Sodium 1-((6-(3-((3-(4-(24,24,25,25,26,26,27,27,28,28,29,29,30,30,31,31,31-heptadecafluoro-
3,3-dimethyl-7,21-dioxo-2,8,11,14,17-pentaoxa-6,20-diazahentriacontan-1-oyl)piperazin-1-
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yl)-3-oxopropyl)thio)-2,5-dioxopyrrolidin-1-yl)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-
sulfonate (Sulfo-NHS-(OEG)3-perfluoroctane) (11) 
To a solution of 10 (10 mg, 24 mM, 1.0 eq.) in anhydrous DMF was added Sulfo-EMCS (25.5 
mg, 25.6 mM, 1.05 eq) and the mixture was stirred at room temperature for 1hour and then for  
additional 3 hours at 40°C. Solvents were removed under reduced pressure and final product 11 
was obtained as pale yellow waxy solid. 1H NMR (400 MHz, DMSO-d6) δ 1.30 (q, J=7.2 Hz, 
2H), 1.38 (s, 6H), 1.49 (q, J=7.2 Hz, 2H), 1.60 (q, J=7.2 Hz, 2H), 1.84 (t,  J=7.6 Hz, 2H), 2.41 
(m, 4H), 2.44 (t, J=7.2 Hz, 2H), 2.62 (t, J=6.8 Hz, 2H), 2.70 (m, 2H), 2.84 (m, 2H), 3.02 (m, 2H), 
3.20 (q, J=6.0 Hz, 2H), 3.30~3.51 (m, 24H), 4.02 (m, 4H), 7.18 (t, J=5.6 Hz, 1H), 8.12 (t, J=5.6 
Hz, 1H). Negative ion ESI-MS: (M-H)-=1383.2. 
 
3.4.5 Synthesis of sulfo-NHS-(OEG)1-perfluoroctane (B in Figure 3.1) 
The compound sulfo-NHS-(OEG)1-perfluoroctane was synthesized according to the procedures 
above for synthesizing its analogue except that (OEG)1 was used instead of (OEG)3. The 
chareacterizations of all intermediates from synthesizing the final product sulfo-NHS-(OEG)1-
perfluoroctane by 1HNMR and ESI-MS are listed below:  
 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-N-(2-(2-
hydroxyethoxy)ethyl)undecanamide 
 
 
N
H
C8F17
O
O
OH
 
1H NMR (400 MHz, CDCl3)  δ 2.49 (m, 2H), 2.56 (m, 2H), 3.50 (t, J=4.8 Hz, 2H), 3.58 (t, J=4.8 
Hz, 2H), 3.59 (t, J=4.4 Hz, 2H), 3.76 (t, J=4.4 Hz, 2H), 6.21 (s, 1H). ESI-MS: (M+H)+ =580.1.  
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2-(2-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecanamido)ethoxy)ethyl (4-
nitrophenyl) carbonate 
 
H
N
O
O
O
C8F17 O
O
NO2  
1H NMR (400 MHz, CDCl3)  δ 2.49 (m, 2H), 2.56 (m, 2H), 3.55 (t, J=4.8 Hz, 2H), 3.62 (t, J=4.8 
Hz, 2H), 3.78 (t, J=4.4 Hz, 2H), 4.45 (t, J=4.4 Hz, 2H), 5.99 (s, 1H), 7.38 (d, J=9.2 Hz, 2H), 8.28 
(d, J=9.2 Hz, 2H). ESI-MS: (M+H)+ =745.08. 
 
17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-heptadecafluoro-2-methyl-6,14-dioxo-
7,10-dioxa-5,13-diazatetracosan-2-yl 4-(3-((3-(4-
(18,18,19,19,20,20,21,21,22,22,23,23,24,24,25,25,25-heptadecafluoro-3,3-dimethyl-7,15-
dioxo-2,8,11-trioxa-6,14-diazapentacosan-1-oyl)piperazin-1-yl)-3-
oxopropyl)disulfanyl)propanoyl)piperazine-1-carboxylate 
 
ON
H
O
O
C8F17
N
H
O
OO
N
NS
O
O
H
N
O
O
C8F17
H
NO
OO
N
N
S
O  
1H NMR (400 MHz, CDCl3)  δ 1.47 (s, 12H), 2.02 (t, J=7.2 Hz, 4H), 2.47 (m, 4H), 2.51 (m, 4H), 
2.76(t, J=7.0 Hz, 4H), 2.95 (t, J=7.0 Hz, 4H), 3.27 (q, J=7.2 Hz, 4H), 3.45 (m, 16H), 3.56 (t, 
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J=5.0 Hz, 4H), 3.60 (m, 8H), 4.20 (t, J=5.0 Hz, 4H), 4.88 (s, 2H), 6.50 (s, 2H). ESI-MS: (M+H)+ 
=1815.4 
 
17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-heptadecafluoro-2-methyl-6,14-dioxo-
7,10-dioxa-5,13-diazatetracosan-2-yl 4-(3-mercaptopropanoyl)piperazine-1-carboxylate 
 
ON
H
O
O
C8F17
N
H
O
OO
N
NSH
O
 
1H NMR (400 MHz, CDCl3)  δ 1.47 (s, 6H), 1.73 (t, J=8.0 Hz, 1H), 2.02 (t, J=7.2 Hz, 2H), 2.49 
(m, 2H), 2.52 (m, 2H), 2.66 (t, J=6.7 Hz, 2H), 2.82 (q, J=7.2 Hz, 2H), 3.29 (q, J=7.2 Hz, 2H), 
3.43 (m, 8H), 3.56 (t, J=5.2 Hz, 2H), 3.63 (m, 12H), 4.21 (t, J=5.2 Hz, 2H), 4.83 (s, 1H), 6.50 (s, 
1H). ESI-MS: (M+H)+ =909.2 
 
sodium 1-((6-(3-((3-(4-(18,18,19,19,20,20,21,21,22,22,23,23,24,24,25,25,25-heptadecafluoro-
3,3-dimethyl-7,15-dioxo-2,8,11-trioxa-6,14-diazapentacosan-1-oyl)piperazin-1-yl)-3-
oxopropyl)thio)-2,5-dioxopyrrolidin-1-yl)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate 
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Negative ion ESI-MS: (M-H)- =1295.3 
 
3.4.6 Labeling ACTH (4-11) using sulfo-NHS-(OEG)3-perfluoroctane 
10 µL of 1mg/mL ACTH (4-11) was diluted in 120 µL PBS 8.0 and the solution was added to a 
vial containing 0.038 mg labeling reagent (Sulfo-NHS-(OEG)3-perfluoroctane, structure see C in 
Figure 3.1). The labeling was proceeded at room temperature for 2 hours and then excessive 
labeling reagent was consumed by reacting with about 0.5 mg polymer-bound tris(2-
aminoethyl)-amine for additional 1hour at room temperature. After centrifugation, the polymer 
beads were washed by 100 µL 80% MeOH and 100% MeOH twice, supernatants were 
combined. 1 µL of the collected supernatant was resuspended in 100 µL 2.5% FA in MeOH for 
direct ESI-MS analysis. The rest was vacuum dried and resuspended in 50 µL TFA for cleavage. 
The cleavage reaction was completed after 1 hour at 37° C. After removal of the TFA under 
reduced pressure, residues were dissolved in 100 µL 50% MeOH containing 2.5% FA for ESI-
MS analysis. 
 
3.4.7 Labeling BSA using sulfo-NHS-(OEG)3-perfluoroctane and affinity purification of the 
labeled tryptic BSA peptides 
10 µL of 10 mg/mL BSA stock solution was diluted in 35 µL PBS 8.0 buffer and the solution 
was transferred to a vial containing 0.26 mg fluorous reagent, followed by a brief vortex. The 
mixture was incubated for 2 hours at room temperature while shaking. The excessive labeling 
reagent was consumed by adding 15 µL of 50 mM tris-HCl for additional 1 hour mixing. The 
labeled BSA was then subjected to in solution trypsin digestion. Briefly, 80 µL of 8.0 M urea 
was added to the labeling mixture, followed by addition of 1.7 µL of 200 mM DTT in 50 mM 
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ammonium bicarbonate  for 1hour reduction at 45°C. 6 µL of 200 mM iodoacetamidein 50 mM 
ammonium bicarbonate  was added for 1hour alkylation at room temperature in dark, and the 
excessive iodoacetamide was consumed by adding 6 µL DTT for an additional 1 hour incubation 
at room temperature. The mixture was diluted by adding 1 mL of 50 mM ammonium 
biocarbonate to final before trypsin (6 µg) digestion at 37° C for 15 hours. The digestion was 
stopped by adding 5% FA till colorless precipitates occurred ( pH≈3.0, hydrolysis by-product of 
the labeling reagent.), which was then separated by centrifugation and further were washed by 
200 µL 5% FA. Combined supernatant were evaporated to dryness and 1/6 sample was 
resuspended in 450 µL  buffer A (20 mM ammonium formate, 0.1 M Acetic acid in 60% MeOH) 
for fluorous affinity purification. Tryptic BSA mixture was loaded onto cartridge packed by 
fluorous silica gel beads at a flow rate 10 µL/min using a syringe pump. After washing by buffer 
A (3 mL) and retained modified peptides were eluted by 2 mL buffer B (20 mM ammonium 
formate, 0.1 M acetic acid in 100% MeOH) at the flow rate of 10 µL/min. The eluate was dried 
under vacuum and resuspended in 95% TFA with 5% anisole as a scavenger for incubation at 
37°C for 2 hours. After removal of solvents, cleaved peptides were resuspended in 50 µL of 5% 
FA, 2% ACN for ESI-LC-MS analysis. 
 
3.4.8 LC-MS/MS analysis and database search 
 LC-ESI MS/MS was performed on a Finnigan LTQTM-ion trap mass spectrometer (Thermo 
Electron, San Jose, CA). Peptide sample (8 µl) was first loaded to a C18 trap column and washed 
with 3% acetonitrile and 0.1% formic acid for 60 minutes for desalting, then the peptides were 
eluted to a reverse-phase C18 analytical column by a 60 minutes gradient made of A buffer (0.1% 
formic acid: 97% water:3% acetonitrile v/v/v) and B buffer (0.1% formic acid: 3% acetonitrile: 
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97% water v/v/v) at a flow rate of  200 ~ 500 nL/min. Separated peptides were analyzed by the 
data-dependent acquisition mode set by Xcalibur, 2.2 version (Thermo Electron, San Jose, CA). 
After a MS survey scan over the m/z range of 300-2000, the seven most intensive precursors 
were selected and subjected to fragmentation by CID (collision induced dissociation). The 
normalized collision energy was set at 35% with activation Q value being 0.25 and dynamic 
exclusion of 100 seconds. The acquired raw data were processed by BioWorks software, version 
3.3(Thermo Electron).  Parameters for SEQUEST database search were set as follows: 
differential mass increase of 57.02 Da on cysteinyl, 15.99 Da on methionine residue, 367.02 Da 
(for Sulfo-NHS-(OEG)3-perfluoroctane labeling) and 99.06 Da (for FBPNHS labeling)  on lysine 
residue respectively. The number of missed cleavage sites was set to three. The search results 
were filtered by cross-correlation score (XCorr) which must be ≥ 2.0 for singly charged ions, 2.5 
for the doubly charged, 3.0 for the triply charged and by delta correlation score (∆Cn) ≥ 0.1. 
MS/MS spectra for detected modified peptides were manually examined to ensure quality of 
identification.  
 
3.5 Results and discussion 
3.5.1 Synthesis of fluorous labeling reagent Boc-pentanoic-NHS-perfluoroctane (FBPNHS) 
The design of our 1st fluorous labeling reagent included fluorous tag (C8F17) moiety for affinity 
enrichment, a reactive group (HOSu derived active ester, NHS ester) targeting free amine groups 
and a TFA labile carbamate linker. The NHS ester was chosen as the reactive group because of 
its well known ability to react with NH2 groups in peptides and proteins in pH=7-9 buffer. The 
carbamate group was selected as the cleavable linker based on robust chemistry and easy 
incorporation into the reagent. Moreover, a relatively long spacer (5 carbon backbone) would 
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reduce the steric hindrance around the NHS ester. The condition that favors the linker cleavage 
was similar to TFA cleavage of the Boc protected amino acids, which has been routinely 
employed in peptide synthesis. The compound was synthesized following the two steps shown in 
Scheme 3.1 with an overall 78% yield. 
 
The first step – production of fluorous tagged Boc group, was relatively easy with high yield. 
The second step however, was not as straightforward. A variety of reaction conditions such as 
using coupling reagents (e.g. DCC, EDC) in the presence of organic bases (e.g. pyridine, DMAP 
and DiPEA) had been explored, but none of those approaches resulted in acceptable 
condensation efficiency as monitored by TLC and mass spectrometry. The efficiency was 
significantly enhanced when NHS was replaced by DSC, an activated derivative of of HOSu, 
which had been utilized in the preparation of active ester (15) and peptide synthesis. Presumably, 
the NHS anions are more easily generated from the attack of carboxylic groups to the carbonyl in 
DSC, which was proven to be more reactive toward deprotonated carboxyl group in the presence 
of pyridine. 
 
3.5.2 Labeling peptides and BSA using FBPNHS  
As proof of principle experiments, the newly synthesized reagent was tested in the labeling of 
some small peptides. After about 30 minutes labeling reaction, a small peptide MRFA gave a 
new peak at m/z: 1155.3, which corresponded to the N-terminally labeled MRFA, the 
unconsumed MRFA at m/z: 524.4 also appeared in the same mass spectrum (Figure 3.2). 
Increasing the amount of the labeling reagent resulted in complete conversion of MRFA to its 
labeled form (mass spectral data not shown). It is interesting that the cleavage of carbamate  
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Figure 3.2. MS spectrum of a modified small peptide MRFA by Boc-pentanoic-NHS-
perfluoroctane after one hour reaction at room temperature. The ion at m/z 524.4 corresponds to 
the unconsumed MRFA and the ion at m/z 1155.3 represents N-terminal modified MRFA. 
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linker was preferred to peptide bond cleavage upon CID (collision induced dissociation). It is 
also noteworthy that no fragmentation of fluorous tag was observed under the CID conditions 
that were optimized for peptide fragmentation; this phenomenon confirmed the inertness of the 
fluorous tag in MS analysis (2).  
 
Longer peptide ACTH (4-11) was also tested and trifluoroacetic acid (TFA) was employed to 
cleave the cabamate linker in the labeled peptides. Results indicated that both the N-terminal and 
the lysine side chain of the peptides were modified as evidenced  
by the appearance of two ions after the cleavage at m/z: 1189.6 (singly tagged) and 1288.7 
(doubly tagged) (Figure 3.3). Its MS/MS analysis (Figure 3.4) revealed that 
C-terminal lysine residue was preferentially modified over the N-terminus in ACTH (4-11) 
possibly because of free amines from the lysine side chain were more accessible to the labeling 
reagent than the ones at N-terminus.  
 
The labeled BSA was digested by trypsin, and the tryptic peptide mixture was treated by ICAT 
cleavage reagents to remove the bulky fluorous label. HPLC-MS analysis followed by database 
search against the amino acid sequence of BSA resulted in the identification of 33 peptides 
among which 11 peptides were labeled by FBPNHS. The FBPNHS labeled peptides covered 
nearly 26% of the BSA sequence (highlighted in blue in Figure 3.5).  
Moreover, a small moiety after the cleavage does not appear to interfere with the peptide 
backbone fragmentation pattern without producing its visible fragments in MS/MS spectrum as 
exemplified in Figure 3.6. 
 
 92
 
 
 
 
 
 
 
Figure 3.3. MS analysis a modified peptide ACTH (4-11) by Boc-pentanoic-NHS-
perfluoroctane after cleaving the fluorous tag. 1090.6 (m/z) indicates the unconsumed peptide 
ACTH (4-11), 1189.6 (m/z) represents the singly tagged ACTH (4-11) and 1288.7524.4 (m/z) 
corresponds to the doubly tagged ACTH (4-11). 
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Figure 3.4. MS2 analysis of singly tagged ACTH (4-11) peptide precursor ion at m/z 1189.6. 
Series of b ions and y ions could be used to confirm the peptide’s sequence. 
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Figure 3.5.  Peptides (highlighted in blue) modified by Boc-pentanoic-NHS-perfluoroctane in 
BSA.  The fluorous tag moiety was cleaved before LC-MS analysis. 
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Figure 3.6.  MS2 spectrum of a BSA tryptic peptide modified by Boc-pentanoic-NHS-
perfluoroctane. The bulky fluorous tag moiety was cleaved before LC-MS analysis.  
 
 
 
3.5.3 Retrosynthetic analysis of 2nd generation fluorous labeling reagent sulfo-NHS-
(OEG)3-perfluoroctane 
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The novel fluorous labeling reagent, sulfo-NHS-(OEG)3-perfluoroctane can be divided to five 
building blocks (a in Figure 3.7). The synthesis of this labeling reagent was based on a 
retrosynthetic analysis (b in Figure 3.7).  The target product, sulfo-NHS-(OEG)3-perfluoroctane, 
can be obtained through a highly efficient coupling reaction between 1  (Sulfo-EMCS, block E in 
Figure 3.7 a) and a thiol compound 2 (block A to D) (in Figure 3.7 a), which could be derived 
from the cleavage of a disulfide bond in its dimmer, compound 3. Compound 3 could be formed 
through a carbamate formation between 4 
and carbonate compound 5 after removal of the Fmoc group with TBAF in DMF. The acid labile 
linker in compound 4 could be constructed through carbonate compound 7 (10) and piperazine 
derivative 6, which be easily prepared from dithiobis[succinimidylpropionate] 9 and 1-Boc-
piperazine 10. Compound 5 could be prepared from hydroxyl compound 8 by reacting with p-
nitrophenylchloroformate. The (OEG)3 spacer in compound 8 could be introduced by the 
incorporation of  (OEG)3-mono-amine 12 to fluorous compound 11 via an amide bond 
formation. The fluorous labeling reagent was synthesized via a 10-step reaction with an overall 
yield of 25%.  
                                                                                                                                                                                   
3.5.4 Characterization of sulfo-NHS-(OEG)3-perfluoroctane by Negative ESI-MS 
The newly synthesized sulfo-NHS-(OEG)3-perfluoroctane was characterized by negative 
electrospray mass spectrometry and 1H NMR (see detailed data in experimental), Dissolved in 
50% MeOH, the labeling reagent could be detected in negative ion mass spectrometry as shown 
in Figure 3.8. Upon collision induced dissociation (CID), the molecular ion [Sulfo-NHS-(OEG)3-
perfluoroctane]- at m/z 1383.30 yielded to two major product ions at m/z 605.0 and m/z 560.90 
(Figure 3.8) corresponding to the product ion (Figure 3.8) from the cleavage at the carbamate 
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bond in block C (Figure 3.7) and subsequent loss of a CO2 (block D and E in a Figure 3.7) 
respectively. Further fragmentation of product ion at m/z 605.0 yielded ion at m/z 560.90 (Figure 
3.8) after the neutral loss of a CO2. The product ion at m/z 560.90 in the MS2 spectrum of m/z 
1383.30 and the m/z 560.90 in the MS3 spectrum of m/z 605.0 are the same, both ions yielded 
m/z 387.01 (spectrum not shown) upon CID, corresponding to the formation of Sulfo-EMCS as 
the result of thiol ether bond cleavage (block E in Figure 3.7 a). These mass spectral evidences 
support the structure of newly synthesized sulfo-NHS-(OEG)3-perfluoroctane as shown in Figure 
3.1 C.  
 
3.5.5 MS2 analysis of ACTH (4-11) labeled by sulfo-NHS-(OEG)3-perfluoroctane 
Sulfo-NHS-(OEG)3-perfluoroctane was employed to label a small peptide ACTH(4-11) (NH2-
M-E-H-F-R-W-G-K) in PBS buffer at room temperature. In a 1 hour reaction, the free amine 
groups (N-terminal and lysine side chain) in ACTH (4-11) were almost completely tagged by the 
labeling reagent (the molecular ion of intact ACTH disappeared and doubly labeled ACTH 
became a major ion on the mass spectrum of the reaction mixture, data not shown). The bulky 
part (correspond to building blocks A + B + C in Figure 3.7 a) of the labeling reagent was 
removed from the labeled ACTH peptide upon treatment with TFA as expected, leaving a small 
tag of 367.17 Da (net mass increase to the amine group in the peptide by building blocks D + E 
after losing the sulfo-NHS group in Figure 3.7 a) remained covalently linked to the N-terminal 
and lysine side chain amine of the peptide. The positive ion ESI MS/MS spectrum of the labeled  
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                                                                                                                              b 
Figure 3.7. Retrosynthetic analysis of sulfo-NHS-(OEG)3-perfluoroctane. a. Structure of 
synthesized the fluorous labeling reagent with indications of its building blocks (A to E). b. 
Retrosynthetic steps for the construction of sulfo-NHS-(OEG)3-perfluoroctane. 
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Figure 3.8. Negative ion ESI-MS of sulfo-NHS-(OEG)3-perfluoroctane and its fragmentation 
pattern. (a) MS spectrum of the labeling reagent showing expected molecular weight after 
deprotonated molecular ion.  (b) MS2 spectrum of precursor ion at m/z 1383.3. The product ions 
at m/z 605.0 corresponds to the cleavage of precursor ion at the tertiary carbamate linkage (TFA 
labile site as well), and ion at m/z 560.9 corresponds to the neutral loss of CO2 from m/z 605.0 
(c) MS3 spectrum of precursor ion at m/z 605.0  showing its further loss of the CO2 to yield ion 
at m/z 560.9. 
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ACTH peptide (after TFA cleavage) is shown in Figure 3.9. Most of the b ions and y ions can be 
observed. Interestingly, a fragment ion at m/z 368.1 which corresponds to the residual of sulfo-
NHS-(OEG)3-perfluoroctane cleaved from the amide bonds formed during the labeling,  also 
appeared on the MS2 spectrum and could serve as a marker of the labeling and fluorous tag 
moiety removal processes. The newly synthesized fluorous labeling reagent indeed efficiently 
modified the free amine groups in peptide. The residual of sulfo-NHS- 
(OEG)3-perfluoroctane after acid cleavage did not interfere with the fragmentation of the labeled 
peptide. 
 
3.5.6 MS2 analysis of BSA peptides labeled by sulfo-NHS-(OEG)3-perfluoroctane  
To further demonstrate the potential of the Sulfo-NHS-(OEG)3-perfluoroctane in protein/peptide 
modification, it was employed to label BSA in PBS buffer. No precipitation was observed 
throughout the labeling reaction, which indicated that the labeling can be performed in aqueous 
solution without introducing any organic solvent to the reaction mixture. After the trypsin 
digestion, the tagged peptides were easily enriched through fluorous affinity purification. After 
TFA cleavage as mentioned above, the tagged peptides were analyzed by LC-MS/MS. About 
95% of the identified peptides were tagged (see Table 3.1). This indicates that affinity 
purification based on fluorine-fluorine interaction was indeed highly effective in enriching 
labeled peptides with low nonspecific binding. The sulfo-NHS-(OEG)3-perfluoroctane tagged 
peptides had longer retention time on reversed-phase C18 column due to the increased 
hydrophobicity introduced by the fluorous alkyl chain. Once the fluorous tag moiety was 
removed, the tagged peptide behaved in the same way as its unmodified counterpart in reversed-  
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phased LC separation. Fifteen out of sixteen tryptic peptides (see Table 3.1) were identified as 
tagged peptides in a single LC-MS/MS experiment followed by database search against BSA 
sequence using  SEQUEST algorithm. As shown in Figure 3.10, the residual of fluorous tag had 
little influence on the fragmentation of the labeled BSA peptide. In addition to the b ions and y 
ions from peptides fragmentation, a characteristic ion at m/z 368.1 appeared on the spectrum 
confirmed that this peptide was labeled by the fluorous reagent. 
 
3.6 Conclusion 
A serial of fluorous labeling reagents were synthesized with aim to effectively react with free 
amine groups on peptides and proteins. The first labeling reagent Boc-pentanoic-NHS-
perfluoroctane (FBPNHS) was synthesized through 2 steps with an overall 78% yield. The 
reactivity of FBPNHS with small peptides (MRFA and ACTH) was tested in water/organic 
mixtures under slight basic conditions. ESI-MS analysis of the product mixture confirmed the 
labeling reaction and MS2 spectrum of the labeled peptide showed that it was normally 
fragmented after removal of the fluorous tag. As one of our novel 2nd generation fluorous 
labeling reagents, sulfo-NHS-(OEG)3-perfluoroctane was also synthesized through 11 steps of 
simple chemical reactions with a high overall yield of 23%. Sulfo-NHS-(OEG)3-perfluoroctane 
also reacts with free amine groups from peptide/protein through an active succinimidyl ester 
group. Notably, the labeling reaction proceeded efficiently in PBS buffer without the need of any 
extra organic solvent in the reaction mixture. More importantly, a homogeneous solution of 
reaction mixture was consistently observed throughout the labeling process, which indicated that 
the fluorous labeling reagent was not only soluble in water, but also didn’t cause any aggregation 
of the labeled proteins due to the incorporation of a hydrophilic (OEG)3 linker. Fluorous affinity 
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Figure 3.9. Positive ion MS2 of peptide ACTH(4-11) tagged by the labeling reagent sulfo-NHS-
(OEG)3-perfluoroctane after TFA cleavage. The peptide was labeled at the N-terminal and the 
lysine side chain. ▲ unique fragment ion at 368.2 m/z from the residual of the cleaved tag. 
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Table 3.1. Identified tryptic peptides derived from sulfo-NHS-(OEG)3-perfluoroctane labeled 
BSA* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Bulky perfluoroctane moiety and OEG linker of the labeling reagent was removed by acid 
cleavage, which resulted in a net mass increase of 367.12 Da on lysine residue. * lysine residue 
modified by fluorous affinity tag, #methionine was oxidized, and @ cysteine was modified by 
iodoacetamide. 
 
 
 
 
 
 
 
 
Detected peptides from elution                  Xc
K.NYQEAK*DAFLGSFLYEYSR.R 6.22
R.ADLAK*YIC@DNQDTISSK.L 6.14
K.GLVLIAFSQYLQQC@PFDEHVK.L 5.80
R.ADLAK*YIC@DNQDTISSK*LK.E 5.55
R.LAK*EYEATLEEC@C@AK.D 5.16
K.EAC@FAVEGPK*LVVSTQTALA 4.86
K.FWGK*YLYEIAR.R 4.43
R.K*VPQVSTPTLVEVSR.S 4.32
K.SLHTLFGDELC@K*VASLR.E 4.28
R.ETYGDMADC@C@EK*QEPER.N 4.17
K.VTK*C@C@TESLVNR.R 3.79
R.ETYGDMADC@CEK*QEPER.N 3.67
R.ETYGDM#ADC@CEK*QEPER.N 3.56
R.ALK*AWSVAR.L 3.39
R.C@ASIQK*FGER.A 3.02
R.C@C@TK*PESER.M 2.64
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Figure 3.10. Positive ion MS2 of a typical BSA tryptic peptide tagged by the labeling reagent 
sulfo-NHS-(OEG)3-perfluoroctane at the lysine residue 
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purification was performed to isolate the tagged tryptic peptides of BSA, majority of peptides 
eluted from the fluorous affinity column were identified by LC-MS analysis as labeled peptides. 
Once the bulky fluorous tag moiety and the OEG linker were removed by acid cleavage, the 
labeled peptides (with a small residue from the fluorous labeling reagent) behaved similar to 
those unlabeled peptide in terms of fragmentation pattern. All these results indicate that labeling 
proteins/peptides by the newly synthesized sulfo-NHS-(OEG)3-perfluoroctane followed by 
affinity separation/enrichment can by incorporated into most of LC-MS based proteomic 
approaches.  
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CHAPTER 4 
 
Surface Exposed Peptide Segments of Candida albicans Cell Wall Proteome 
Characterized by in vitro and in vivo Chemical Labelings and LC-MS 
 
4.1 Abstract 
 
The fungal pathogen Candida albicans is one of the major causes of candidiasis which results in 
high mortality among various immunocompromised hosts (such as AIDS patients). Cell wall 
proteins (CWPs) play essential functions in this pathogen’s colonization, invasion and induction 
of immune response from hosts. Information on the dynamic regulations of CWPs during the 
morphological transition from yeast to hyphae provides better understanding on the mechanism 
of pathogen-host interaction. Cell surface biotinylations at low temperature (4°C), enzymatic 
digestion of the intact fungal cell surface proteins (“whole cell shaving”), biotin-avidin affinity 
enrichment of biotinylated peptides, liquid chromatography mass spectrometry (LC-MS) based 
proteomic approach were employed for unambiguous identification of cell wall/cell wall 
associated proteins and the exposed peptide segments of these proteins. SILAC (Stable Isotope 
Labeling by Amino acids in Cell Culture) based CWP quantification analyses were performed to 
monitor CWP accumulation level change in response to germination. 148 CWPs of yeast form of 
C. albicans were identified based on stringent criteria through intact cell labeling by three 
biotinylation labeling reagents. Characteristic fragments originated from biotin tag on tandem 
mass spectra of labeled peptides were also employed to verify that the peptides were indeed 
labeled. Notably, fifty one proteins found in our study were not reported in the literature as 
CWPs or cell wall associated proteins.  Metabolic labeling of proteins with isotopic coded lysine 
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during yeast germination followed by and SDS-DTT (sodium dodecyl sulfate-dithiolthreitol)  
extraction allowed us to quantify one hundred and eighteen cell wall-associated proteins, among 
which ninety two proteins were up-regulated and twenty four proteins were down-regulated with 
one yeast specific protein and one hyphae specific protein. Surface exposed peptide segments of 
CWPs determined in this study could be new candidates to the pool of potential peptide targets 
for protective vaccine development. 
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4.2 Introduction 
 
The cell surface of C. albicans is the frontier where initial interaction takes place between the 
fungus and the host. Cell surface proteins are likely those members in cell wall matrix to initiate 
fungal adhesion, colonization, pathogenic invasion and therefore modulation of immunological 
response from the host (68). Studying the surface proteome of C. albicans is essential for gaining 
a further understanding on the mechanism of the host-pathogen interactions. A paradigmatic 
approach was established to profile the surface proteins in fugal species using Saccharomyces 
cerevisiae as a model (93), featuring protein extraction via an array of chemical/enzymatic 
means, protein separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and protein detection by mass spectrometry (MS) (66). With the recent advancement in 
mass spectrometry based proteomic techniques, especially the coupling of MS and SDS-PAGE 
and/or liquid chromatography (LC), characterization of fungal cell surface proteins has reached 
an unprecedented level both qualitatively and quantitatively. For instance, non-gel based 
methods were complementary to 2D-SDS-PAGE, which was not efficient in glycoprotein 
separation (31, 92). A “whole cell-shaving” technique using proteolytic enzymes (usually 
trypsin) was employed to release peptides from surface accessible proteins of Cryptococcus 
neoformans (22) without the need of laborious protein extraction procedures. Moreover, labeling 
the whole fungal cell surface proteins by membrane impermeable biotinylation reagent (87) 
offered an alternative approach to differentiating surface proteins from cytosolic contaminants. 
The labeled proteins can be enriched through avidin affinity chromatography followed by SDS-
PAGE separation. A typical cell membrane impermeable biotinylation reagent consists of two 
moieties: a biotin group and a peptide reactive group. The peptide reactive moiety of 
biotinylation reagents usually targets either the free amine groups (82)or free thiol groups (55) in 
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protein/peptides. These labeling methods were successfully employed in the detection of Pir 
(Protein with internal repeats) proteins in S. cerevisiae (51), Pir and Tsa1p in C. albicans (35) 
(87). During avidin-biotin affinity purification of the labeled proteins/peptides, unlabeled 
proteins/peptides may nonspecifically bind to avidin and eventually result in false identification. 
This non-specific binding problem could be aggravated especially in the purification of heavily 
glycosylated cell wall proteins.(49)  
  
The accumulation level of C. albicans cell wall/surface proteins is highly dynamic and often 
correlates with the extracellular environment. The dynamic change of cell wall/surface is 
especially prominent during the conversion from yeast to hyphae of this pathogenic fungus. 
Switching to hyphae is believed to be a necessary process for the pathogen’s penetration into 
epithelia, endothelia and tissue as a result of the morphological adaptation of the fungal cell, 
thereby contributing to its virulence in vivo (57). The morphogenesis is orchestrated by a wide 
spectrum of complex signal network pathways under certain stimulus factors such as elevated 
culture temperature at 37° C (29). Understanding the surface proteomic change of C. albicans 
during morphogenesis is essential to the elucidation of fungal pathogenesis, thereby shedding 
lights on the path of new drug target discovery.  In previous studies, comparative 2D-PAGE 
based approaches were employed to quantify the surface proteome change during a yeast to 
hyphae conversion of C. albicans (66) (20).  A small number (24) of proteins were found to be 
differentially regulated before and after germination (20), probably due to the complicated 
sample preparation procedure and the incompatibility of the gel-based method employed in the 
cell wall protein separation. More recently, a comprehensive proteomic analysis of cytoplasmic 
proteins and cell wall associated proteins from yeast cells, hyphae, and biofilms of C. albicans 
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has been reported by Gil and co-workers(47). Compared to the conventional 2D-PAGE based 
approaches, 2D-DIGE (2-D Fluorescence Difference Gel Electrophoresis) technique 
significantly enhanced the capacity of protein quantification.(1)  In addition to the 2D-PAGE 
based comparative proteomic analysis, stable isotopic labeling techniques has more attractive 
advantages such as good reproducibility, high accuracy and high throughput in protein 
quantification (34). SILAC (61) is one of the important isotopic labeling methods and has been 
successfully applied in various biological systems (74) (43) (88). The first step in SILAC method 
is to metabolically label proteins through the incorporation of essential or nonessential amino 
acids to living cells. Lysine is commonly chosen for its relative high abundance in proteins and 
presence in the peptides produced by trypsin digestion. Relative quantification of protein can be 
achieved by comparing the chromatographic peak areas of two paired peptides with the isotope 
coded amino acid residues. Another advantage of the stable isotopic tagging is that it can be 
introduced in vivo at early stages of cell growth; thereby variations due to sample preparation, 
which were commonly observed in in vitro labeling, can be greatly reduced. One major 
disadvantage inherent with the SILAC is that it can not be applied to microbes which do not 
normally need any exogenous amino acids.  Fungal cells (including C. albicans) are just one 
such organism. Fortunately, this issue can be addressed through choosing a mutant strain which 
is auxotrophic for certain amino acids such as lysine.(5)  
 
In this study, the cell surface proteome of C. albicans was profiled by intact cell surface 
biotinylation labeling technique coupled with LC-MS identification of surface exposed peptide 
segments. Characteristic fragments originated from biotin tag moiety on tandem mass spectra of 
peptide were employed to confirm that the peptides were labeled. Facilitated by the availability 
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of a lysine production deficient mutant, the dynamic change of the surface proteome during 
morphogenesis was quantified by using a SILAC based method which involved in an in vivo 
stable isotope coded lysine labeling technique. 
 
4.3 Experimentals 
4.3.1 Yeast strains 
C. albicans 6284 was the result of repairing strain BWP17 to prototrophy (69). It was a gracious 
gift from Dr. G. Palmer (Louisiana State University Health Sciences Center, New Orleans, LA). 
Strain CLD2 was obtained after sequential disruption of the LYS2 alleles and auxotrophic for 
lysine (5). It was generously given as a gift from Dr. J. K. Bhattacharjee (Department of 
Microbiology, Miami University, Oxford, OH). 
 
4.3.2 Cell surface labeling with biotinylation reagents 
C. albicans 6284 were cultured on YPD plate (Becton, Dickinson and Company, Franklin Lakes, 
NJ) at 37 ° C for 2 days. Cells were slightly scratched off the medium using sterilized pipette 
into 1.5 mL centrifuge tube and consequently washed by ice-cold phosphate-buffered saline PBS 
pH 7.4, five times with final OD600=2.7-2.8 in 1mL PBS 7.4. Biotin labeling reagent (sulfo-
NHS-LC-biotin or sulfo-NHS-SS-biotin or iodoacetyl-PEO2-biotin) (Pierce, Rockford, IL) (14 
mM) in 300 ul of ice cold PBS 8.0 was added to the washed cells. After a short vortexing to form 
a cell suspension, the mixture was incubated at 4°C with 400 rpm mixing in a cold room for 2 
hours.  When  iodoacetyl-PEO2-biotin reagent was used, intact yeast cells were initially treated 
by 10 mM tris-(2-carboxyethyl) phosphine (TCEP) (Promega, Madison, WI) at 4°C for 20 
minutes prior to the incubation step, and the  cells were washed again by PBS 7.4 3~5 times 
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before the labeling. The labeling reaction was quenched by adding ice cold 1 mL of 50 mM Tris-
HCl (pH 8.0) and by further incubation at 10°C for 15 minutes. Finally the labeled cells were 
extensively washed by ice cold PBS buffer (pH 7.4) to remove by-products of the biotinylating 
labeling reaction. 
 
4.3.3 Tryptic digestion of intact cells (“whole cell shaving”) and peptides extraction  
Yeast cells labeled with sulfo-NHS-LC-biotin or iodoacetyl-PEO2-biotin were first washed by 1 
mL of 50% methanol two times and suspended in 500 µL 50 mM ammonium bicarbonate. To 
this suspension of yeast cells, 15 µl of 200 mM dithiothreitol (DTT),(Sigma, St. Louis, MO) was 
added followed by 40 minutes incubation at room temperature. 7 µL of 1 M iodoacetamide (IA) 
(Sigma, St. Louis, MO) was added to the cell suspension followed by an additional 40 minutes 
incubation at room temperature. After centrifugation, cell pellets were washed by 500 µL of 50 
mM ammonium bicarbonate three times. Finally, 8 µg trypsin in 40 µL of 50 mM ammonium 
bicarbonate was added to the cell pellet followed by a brief vortexing.  The trypsin digestion was 
carried out at 37°C for 18 h. For sulfo-NHS-SS-biotin labeled cells, washing the cells with 60% 
MeOH was conducted instead of dithiothreitol/iodoacetamide (DTT/IA) treatment before trypsin 
digestion. 
 
The digestion was stopped by freezing the sample in liquid nitrogen. Supernatant containing 
soluble peptides were collected. More tryptic peptides were subsequently extracted by acidic 
water (5% formic acid), 10% ACN, 30%ACN and 50% ACN. Extracts were combined and then 
evaporated to dryness in vacuum. 
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4.3.4 Affinity enrichment of biotinylated peptides 
Extracted peptides after “whole cell shaving” were first purified using ICAT-cartridge-cation 
exchange column (Applied Biosystems, Foster City, CA) to remove DTT, IA and trypsin. 
Peptides labeled by non-cleavable reagent were enriched on cartridge-avidin column according 
to the protocol provided with the ICAT reagent kit (Applied Biosystems, Foster City, CA). After 
vacuum drying at room temperature, the labeled peptides were dissolved in 3% ACN containing 
1% formic acid for LC-MS/MS analysis. 
Sulfo-NHS-SS-biotin labeled peptides were incubated in 0.2 mL neutravidin beads (Pierce, 
Rockford, IL) in 200 µl binding buffer (2×PBS pH 7.2) at room temperature for 1 hour with 
mixing. After centrifuge, supernatant was discarded and the beads were washed three times by 2 
mL of PBS (pH 7.2),  2 mL of PBS ( pH 7.2 ) containing 1% Triton X-100, 2 mL of 50 mM 
ammonium bicarbonate in 20% MeOH and finally 2 mL of H2O. The beads were incubated in 
250µL of 20 mM TCEP at room temperature for 30 minutes to release the labeled peptides. The 
reduction and extraction process were repeated two times followed by additional four times 
washing of the bead with 5% ACN. All extracts and washes were combined and vacuum dried 
before LC MS/MS analysis. 
 
4.3.5 In vivo isotopic lysine labeling during germination growth of yeast 
Lys2- auxotroph strain (C. albicans CLD2) cells (5) were first streaked on a YPD ((1% yeast 
extract, 2% bacto peptone, 2% glucose) plate and incubated for 3 days at room temperature. A 
single colony was then selected and resuspended in 5 mL of liquid YPD medium in a centrifuge 
tube for pre-culturing at 25°C for 10 hours.  These cultures were inoculated in 100 mL of YPD 
with a dilution of 1:200 and grown under 25°C for 36 hours as yeast cells. Cells were harvested 
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by centrifugation under 4°C and extensively washed by cold PBS buffer (pH 7.4). Cells were 
subsequently inoculated at 8x106 /cells in 100 mL SILAC DMEM (minus lysine and arginine) 
(Pierce, Rockford, IL) which had been supplemented by isotopic labeled lysine (K*.2HCl, 180 
mg/L) (Cambridge Isoptope Laboratories, Andover, MA), arginine (R.HCl, not isotopic labeled, 
84 mg/L) (Sigma, St. Louis, MO) and HEPES (5.958 g/L) (EMD Chemicals Inc., Gibbstown, 
NJ). After 2 hours of germination at 37 °C hyphae cells were then harvest by centrifugation 
under 4°C and repeatedly washed by cold PBS buffer (pH=7.4).  
 
4.3.6 Extraction cell wall proteins by SDS-DTT  
A cell wall fraction was prepared according to procedures described previously with some 
modifications (66). Briefly, hyphae cells were washed 3 times by ice cold lysis buffer (10 mM 
Tris-HCl, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, PMSF), resuspended in cold lysis buffer 
and transferred in screw capping vials which contained equal volume of glass beads (425-600 
µm in diameter, acid washed). The cells were mechanically broken with the glass beads in a dry 
ice precooled bead mill cell homogenizer at the maximum speed for 45s for 7 cycles with 
intermittent cooling on ice immediately after each cycle in a cold room (4°C). The complete cell 
breakage was confirmed by microscopic examination and failure of cell growth in YPD-
chloramphenicol (10 µg/mL) plates. Glass beads were filtered out through a sponge packed 10 
mL syringe and washed by cold lysis buffer untill the washing solution was clear. Crude cell 
wall pellet was separated from of soluble cytosolic fraction after centrifugation at 2000 g for 10 
minutes at 4°C. The collected cell wall fraction was washed and vortexed in 10 mL of cold 1mM 
PMSF solution for 3 times. The wall pellet was subjected to extensive washing and vortexing by 
a gradient of cold 10 mL NaCl solution (5%, 2%, 1% in 1mM PMSF) for 5 times each. The 
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pellet was finally washed by another 10 mL of cold 1 mM PMSF again. The washed cell wall 
fraction was boiled in 300 ul of SDS extraction buffer (2% SDS, 0.1 M EDTA, 15 mM freshly 
made DTT, 50 mM Tris-HCl, pH 8.0) for 4 times of 10 minutes. The supernatants were 
combined for the first three extractions after centrifugation at 1000 g for 10 minutes and the 4th 
extract was discarded. SDS extracted proteins were immediately carboxyamidomethylated with 
500 mM iodoacetamide (4 fold mole excessive to DTT in the extracts) at room temperature for 1 
hour in the dark.  SDS extracted proteins were precipitated by CHCl3/MeOH (90). The protein 
pellet (SDS-DTT extracted cell wall protein) was stored at -80°C for future use.  
 
4.3.7 SDS-gel electrophoresis (PAGE) and in-gel digestion 
The protein pellet from SDS extraction was suspended in 1% SDS and heated at 90°C for 2 
minutes. After a brief vortexing to solubilize the pellet, protein concentration was determined by 
BCA. Protein samples (three biological replicates, 100 µg for each sample) were loaded onto 
each well of a mini-gel, separated by SDS-PAGE  9% acrylamide gels and stained by Coomassie 
blue. Stained bands for each sample were excised and in-gel digested as previously described 
(71). 
   
4.3.8 LC-MS/MS analysis and database search 
LC-ESI MS/MS was performed on Finnigan LTQTM-ion trap mass spectrometer 
(ThermoFinnigan, San Jose, CA) coupled with a Finnigan Micro Auto Sampler. Vacuum-
concentrated samples (not completely dried) were suspended in 25 µL of 5% acetonitrile and 5% 
formic acid in a ninety six well micro plate and the volume for each sample injection was 8 µL. 
The sample mixture was first loaded to a C18 trap column and washed with 3% acetonitrile and 
 117
0.1% formic acid for 60 minutes for desalting, then the purified peptides were eluted to a 
reverse-phase C18 analytical column by a 60 minutes gradient made of A buffer (0.1% formic 
acid: 97% water:3% acetonitrile v/v/v) and B buffer (0.1% formic acid: 3% acetonitrile: 97% 
water v/v/v) at a flow rate of  200 ~ 500 nL/min. Separated peptides were analyzed under the 
data-dependent acquisition mode set by Xcalibur, 2.2 version (Thermo Electron). After a MS 
survey scan over the m/z range of 300-2000, seven (three for samples from SILAC labeling 
experiments) most intensive precursors were selected and subjected to fragmentation by CID 
(collision induced dissociation). The normalized collision energy was set at 35% with activation 
Q value being 0.25 and dynamic exclusion of 100 seconds. The acquired raw data were 
processed by BioWorks software, version 3.3 (Thermo Electron) and tandem mass spectra were 
searched against a C. albicans protein database (downloaded from NCBI) by using SEQUEST 
algorithm. 
 
Parameters for SEQUEST database search were set as follows: differential mass increase of 
414.19 Da on cysteinyl (for iodoacetyl-PEO2-biotin labeling), 340.1 Da on lysine residue (for 
sulfo-NHS-LC-biotin labeling), 88.01 Da on lysine residue (for sulfo-NHS-SS-biotin labeling) 
and 8.00 Da (for SILAC labeling) in addition to 57.02 Da on cysteinyl and 15.99 Da on 
methionine residue. The number of missed cleavage sites was set to three. The output for the 
search results was filtered by cross-correlation score (XCorr) which must be ≥ 3.0 for the triply 
charged ions, ≥ 2.5 for the doubly charged ions and  ≥ 2.0 for the singly charged ions. Also, delta 
correlation score (∆Cn) was set to be ≥ 0.1. MS/MS spectra of all the biotinylated modified 
peptides were manually inspected to ensure the quality of spectra. “Pepquan” tool in BioWork 
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3.3 was used for SILAC protein quantification. Chromatographic peak areas of peptide pairs 
were manually inspected or adjusted to ensure accurate quantification. 
 
4.4 Results and Discussion 
4.4.1 Surface protein profiling by three biotinylating reagents and LC-MS  
The intact yeast form of C. albicans 6284 was labeled with three membrane impermeable 
biotinylation reagents respectively at low temperature. These labeling reagents were routinely 
used in cell surface biotinylation method (23) as a procedure to reduce possible cytosolic 
contamination in the cell membrane protein fraction (21). Sulfo-NHS-LC-biotin and sulfo-NHS-
SS-biotin target free amine groups in the side chain of lysine residue and unmodified N-termini 
of proteins, while iodoacetyl-PEO2-biotin reacts with cysteine residues. To maximize the 
sequence coverage, confirm the labeling and test the efficiency of those reagents in the 
bitotinylation of C. albicans cell surface proteins, all three labeling reagents were employed. In 
order to reduce the potential cell response to the labeling reactions, the labeling procedures were 
conducted at low temperature (4°C) in PBS (8.0) buffer. Urban’s group also confirmed the 
efficacy of the labeling and membrane impermeability of sulfo-NHS-LC-biotin by using 
colloidal gold immunoassay (87).  
 
Unlike other methods in which cell wall fractions were prepared from cell lysate or biotinylated 
proteins were enriched after the labeling process, the “whole cell-shaving” method employed in 
our experiments yielded labeled peptides by trypsin digestion of the intact fungal cells. The 
“shaving” technique had been previously utilized to identify bacterial surface proteins for 
vaccine candidates search (70). We employed this technique with an aim to preferentially cleave 
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surface proteins mostly exposed to the extracellular environment. Also, membrane proteins (such 
as GPI anchored proteins) are likely to be shielded by outer cell wall proteins and partial trypsin 
digestion of these proteins was expected. However, this “whole cell shaving” technique could 
not totally eliminate cytosolic contamination,  as the DTT/IA treatment of the whole fungal cell 
might damage the plasma membrane and lead to leakage of cytosolic proteins (36). Avidin 
affinity chromatography allowed us to enrich biotinylated peptides from a highly complex 
mixture of peptides, but the enriched biotinalyted peptide fraction may still contain digested 
cytosolic proteins. Fortunately LC-MS and bioinformatic analyses of enriched biotinalyted 
peptide fraction would provide unambiguous information as to which peptide was biotinalyted, 
and thus determine the cell wall/surface location of the protein from which the biotinayated 
peptide was derived.  
 
LC-MS analysis yielded tandem mass spectra of peptides in the enriched biotinalyted peptide 
fraction. Database searches were subsequently performed on the peptide tandem mass spectra by 
using SEQUEST algorithms. Once a tandem mass spectrum was determined to match a peptide 
sequence, the search result would also include information on which amino acid residue (s) was 
(were) modified by the labeling reagent defined prior database search. Moreover, characteristic 
fragments originated from the labeling reagent further confirmed that the peptide was labeled. 
Figure 4.1B is a tandem mass spectrum of peptide ion at m/z: (the precursor ion was detected in 
MS spectrum as shown in Figure 4.1A). The b ions and y ions in the spectrum provided 
information about the sequence of the peptide as well as which amino acid residue was modified 
by the labeling reagent (sulfo-NHS-LC-biotin).  Two fragment ions at m/z 340.2 and m/z 227.1 
were originated from the sulfo-NHS-LC-biotin tag (see Figure 4.1C).  As for iodoacetyl-PEO2-
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biotin labeled peptides, characteristic fragment ions at (m/z):  449.1, 375.2, 332.2 and 270.1 
corresponding to the cleavage sites as shown in Figure 4.2 could also be observed for the 
biotinylated peptides upon CID. These fragment ions originated from iodoacetyl-PEO2-biotin tag 
were comprehensively studied previously (7). 
 
Even though sulfo-NHS-SS-biotin labeled peptides do not yield characteristic fragments that can 
be retrieved to the labeling reagent, the tandem mass spectra of the labeled peptides contains 
enough information for the sequence and modification site(s) determination (data not shown). It 
should be noted that biotinylated peptides determined in the above mentioned experiments not 
only confirmed the cell surface localization of the proteins from which they were derived, but 
also represented the peptide segments of these surface/surface affiliated proteins that were likely 
exposed outside to the extracellular environment. For instance, several biotinylated peptides 
were detected for CaPMA1 plasma membrane H+-transporting ATPase (CA 2300). The detected 
peptides ( Figure 4.3 (A)) were located in the hydrophilic loops that were likely exposed to the 
outside as predicted by TopPred (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html) 
(Figure 4.3 (B) ), rather than in the more hydrophobic parts that might be buried in the cell wall 
or cell membrane.  
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Figure 4.1. An example of LC-MS analysis of enriched peptide released from C. albicans cells 
labeled by sulfo-NHS-LC-biotin. (A) Precursor ion 620.31 (m/z) was selected for MS/MS 
experiment.  (B) The MS/MS spectrum for the precursor ion 620.31 (m/z). The “b” and “y” ions 
are labeled together with the two biotin moiety specific ions of 227.1 (m/z), 340.2 (m/z). The 
peptide was identified by SEQUEST as VPK@SLLDK (K@, modified lysine residue). (C) Two 
characteristic fragment ions produced upon CID from the biotin moiety attached to a lysine 
residue 
 
B 
C 
A 
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Figure 4.2. MS/MS spectrum of an iodoacetyl-PEO2-biotin labeled peptide matched the 
sequence of VILC#GEETLEER as a result of SEQUEST search. Four tag specific ions at m/z: 
270.1, 332.2, 375.2, and 449.1 can be observed.   
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Figure 4.3. (A) Part of amino acids sequences of CaPMA1 plasma membrane H+-transporting 
ATPase and peptides detected by labeling  using sulfo-NHS-SS-biotin (highlighted in dark red), 
iodoacetyl-PEO2-biotin (highlighted in blue) and Sulfo-NHS-LC-biotin (highlighted in green)  
respectively (B)  Topology of  CaPMA1 predicted  by TopPred from  
(http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html). Lines colored in brown and blue 
corresponding to the peptides in the same color shown in (A). 
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4.4.2 Cell wall proteins identified based on the detection of biotinylated peptides 
Based on this approach, LC-MS analysis of biotin-avidin affinity enriched tryptic peptides 
resulted in the identification of more than 200 proteins. The experiments included: 1. whole cell 
labeling by sulfo-NHS-LC-biotin or sulfo-NHS-SS-biotin or iodoacetyl-PEO2-biotin; 2. trypsin 
digestions of the labeled whole cell to release peptides; 3. biotin-avidin enrichment of the 
biotinylated peptides; 4. LC-MS/bioinformatic analyses of the biotinylated peptide enriched 
fraction. Among these 200 plus proteins, one hundred and fourty eight cell wall proteins 
(supplemental Table S1) were assigned based on the detection of multiple biotinylated peptides 
(see Table 4.1 for examples).  If protein identification was based on three or less peptides, the 
tandem mass spectra of the peptides were manually inspected for biotin tag specific ions to 
verify the identification. This study, to our knowledge, is the most accurate profile of cell surface 
proteome of C. albicans, because the identification of proteins was based on the detection of 
labeled peptides, and in some cases was further confirmed by the characteristic fragment ions 
originated from the biotinylation labeling reagent. In our experiments, fifty one proteins were 
identified as cell wall proteins for the first time (highlighted in green in supplemental Table S1). 
Among these fifty one identified proteins, twenty seven were identified by only one biotinylated 
peptide, possibly due to the low abundance of these proteins. Even though these twenty seven 
proteins had never been reported as cell wall proteins, their cell wall/surface localization could 
be confidently assigned based on the unambiguous detection of biotinylation labeling reagent 
modified peptide, i.e. detection of the exposed peptide segment of this protein.  
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Table 4.1. A short list of 5 examples of identified cell surface proteins of C. albicans strain 6284 
based on detection of biotinylated peptide(s) by LC-MS 
 
 
Note: The accession numbers are adopted from Candida DB 
(http://genodb.pasteur.fr/CandidaDB). K&: lysine residue modified by sulfo-NHS-LC-biotin; 
K#: lysine residue modified by sulfo-NHS-SS-LC-biotin; C@: cysteine residue modified by 
iodoacetyl-PEO2-biotin 
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Three biotinylation reagents, sulfo-NHS-LC-biotin, sulfo-NHS-SS-biotin, and iodoacetyl-PEO2-
biotin, were employed in three similar approaches to identify cell wall/surface proteins of C. 
albicans. Each approach has unique protein identifications, and there were also protein 
identifications shared by different approaches (Figure 4.4) (supplemental Table S1). Twenty 
proteins (GAP1 TEF1, SSA4, FBA1, PDC11, PGK1, EFT2, TPI1, MET6, PET9, RPL3, SSB1, 
SAH1, HXK2.3f, ACH1, CHT2, RPL82, ATP2, IPF2431, PMA1) were detected in all the three 
approaches, which implies that these proteins may have relative high abundance in the cell 
wall/surface. The repetitive detection of these proteins also confirmed their cell wall localization 
and the corroborative nature of the three approaches. Surprisingly, ACH1, SAH1 were never 
reported in literature as cell wall proteins even though they could be regarded as abundant 
proteins in our study. It seems that these proteins may also have known cytosolic functions such 
as acetyl-CoA hydrolase activity (for ACH1) and adenosylhomocysteinase activity (for SAH1), 
but their roles in cell wall remain unknown. These two proteins may be regarded as secreted 
proteins since they were both detected in the serum from patients under systemic candidiasis 
(64). SAH1 may also contribute to the biofilm formation of C. albicans and act as an adhesion 
molecule to host (25). ENO1 was identified as one of the most abundant cell wall proteins in our 
study with the detection of twenty eight peptides labeled by sulfo-NHS-LC-biotin or sulfo-NHS-
SS-biotin (but not by iodoacetyl-PEO2-biotin because it has no cysteine residue in its sequence). 
It was also previously identified as a major cell wall glycolytic enzyme located in the inner 
layers of the glucan wall matrix via  monoclonal antibody probing and immunoelectron 
microscopy(3),  and this protein might be account for 0.7 and 2% of the total protein in both 
yeast and hyphae cells (83). Edwards group (21) first detected the presence of Enolase in the  
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Figure 4.4. Pie graphic representation of detected cell wall proteins biotinylated by three 
labeling reagents. 95 proteins were detected via labeling by sulfo-NHS-SS-biotin (dark red), 69 
by iodoacetyl-PEO2-biotin (in blue) and 79 by sulfo-NHS-LC-biotin (in green).   
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cell wall of S. cerevisiae, which prompted them to propose an alternative secretion pathways for 
proteins without signal sequences. Other proteins (labeled by all three labeling reagents), such as  
FBA1, MET6, PGK1, SSB1, TEF1, TPI1 and TSA1 are mainly involved in pathogen- host 
interactions. FBA1, MET6, PGK1, SSB1, and TPI1 showed immunogenecity in a murine model 
and could be induced by symbiote of host defense response (65). Interestingly, ribosomal 
proteins (RPL3 and RPL82) and translational elongation factors (EFT2 and TEF1) were also 
detected as abundant cell wall proteins. Although their functions at cell wall were unknown, they 
had been shown to be highly antigenic both in mouse and human (48) 
 
The largest overlapping proteins were detected by both of the two approaches that involved in 
sulfo-NHS-LC-biotin and sulfo-NHS-SS-biotin. These thirty eight cell wall proteins include 
ENO1, ADH1, ECM33.3, RPL2.3, RPL17B, RPS15.3, CIT1, RPL18, RPL19A.3, GAD1, 
RPS31, RPL23B.3, RPL7A.3, IPF8762, PRA1, RPL28.3f, IPF14171, RPS4, KAR2, HHF21, 
RPS3, PGI1, ICL1, POT14, SSC1, HTA1, RPL10, RPL32, HSP70, RPL6.3, IPF9926, RPS22A, 
HTB1, EFB1, ACT1, ADK1, RPS19A.3, AMYG1. This large overlapped detection was because 
that both labeling reagents targeted the same functional group (amine) in cell wall proteins. 
Interestingly, for the same protein detected by both approaches, each approach detected different 
regions. For example, sulfo-NHS-LC-biotin detected K&NPROFGLLVALDAEGTASGK (& 
indicates the biotinylation site) while sulfo-NHS-SS-biotin labeled 
K+NPFGLLVALDAEGTASGK (+ shows the biotinylation site), although both labeling 
reagents identified the same protein AMYG1. Since the cells were labeled under the same 
conditions, the difference in the detection of labeled peptides could be due to the peptide elution 
process during affinity enrichment. The sulfo-NHS-SS-biotin labeled peptides were released 
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from the avidin column via the reductive cleavage of the disulfide bond, and the released peptide 
has a smaller tag than sulfo-NHS-LC-biotin labeled peptides.  
 
The overlapped detection shared by approaches involved with sulfo-NHS-SS-biotin and 
iodoacetyl-PEO2-biotin includes seventeen proteins (PCK1, MLS1, CDC19, PDA1, GND1, 
CEF3, GPH1, CAR2, GCV2, ADH2, RPS23, IPF17186, RPL10A, ZWF1, ACO1, RPL12, 
IDH2). These two labeling reagents target different functional groups. Similarly, the overlapped 
detection shared by sulfo-NHS-LC-biotin approach and iodoacetyl-PEO2-biotin approach include 
six proteins (RPS10, SRB1, RPS6A, NCP1, PHR2, RPL4B). It should be noted that large set of 
proteins were detected in each approach (ATP1, GPM1, QCR2, IFD4, TAL1, RPL13, LPD1, 
IPF9803, TKL1, IDH1.3, VMA4, GCV1, RBT5, HHT21, CDC48, AMS1, IPF11299, HSP90, 
HHT3, KRS1, FDH11.3, IPF3358 in sulfo-NHS-SS-biotin labeling approach; ALD5, IPP1, 
HSP60, MIS11, MDH1, FAS2.5f, SCW1, SAC6.5f, HEM13, ADO1, CHC1, RIB3, ARO4, 
IPF11123, YNK1, AAT1, FBP1, ADE6, MNT1, ARA1, CPR3, VMA2, IPF6629, ADE17, 
IPF9550, BMH2, IPF470, TRX1 in iodoacetyl-PEO2-biotin labeling approach, and ALS4.5f, 
CYP1, UCF1, IMH3, BGL21, IPF17237, PDI1, ADH5, MCR1, GSP1, ATP4, FUM12.5f, 
IPF11888, KES1, SOD21, ACC1, NTF2 in sulfo-NHS-LC-biotin labeling). Sulfo-NHS-SS-
biotin had been chosen by other investigators (63) to reduce possible intracellular labeling since 
the reductive cytosolic milieu would potentially cleave the disulfide bond in the labeling reagent, 
(6) therefore affect the enrichment of  labeled cytosolic proteins. Contrary to this theory, we 
found that the sulfo-NHS-SS-biotin labeling approach detected the largest number of proteins, 
and it might imply that proteins detected by biotinylation were not related to the cytosol.  
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 4.4.3 Localization of identified putative cell wall proteins 
All identified cell wall proteins were analyzed by Gene Ontology (GO) (8) (4) Slim Mapper at 
CGD (http://www.candidagenome.org/cgi-bin/GO/goTermMapper) with a filter set for 
“annotations from High-throughput Experiments” and “the Manually Curated”. As shown in 
Figure 4.5, 55.8% of the identified proteins have been fully annotated. Majority of the annotated 
proteins were cell wall (25.9%), plasma membrane (20.4%), membrane associated (7.5%) and 
extra cellular region (4.8%) proteins. This result demonstrated that biotinylating reagents were 
selective in labeling cell wall/membrane proteins.  BGL2 was a classical yeast form cell wall 
protein of C.albicans which had been confirmed to have cell surface location (33, 66) (12). It 
should be noted that many proteins identified in our study might have multi-locations. For 
example, ENO1 was classified in six locations (cell wall, membrane, plasma membrane, 
cytoplasm, membrane fraction and extracellular region). ADH1, ENO1, HSP70, HSP90, and 
PGK1 from cell wall fraction were also assigned as cytosolic proteins (5 out of 19). It is quite 
common in microbes that proteins may have multiple localizations, and a term “moon-lighting” 
was coined for those proteins with an emphasis for their second function in the cell wall. Also, a 
new mechanism (59) of protein exporting had been proposed for cell wall proteins that lacked an 
N-terminal signal sequence for secretion. An increasing number of proteins without N-terminal 
signal peptide had been found in both S. cerevisiae and C. albicans and were compared in a 
recent review (59). Detection of conventional cytosolic proteins in this study is consistent with 
previous reports in which the surface presence of highly abundant proteins (GAP1, FBA1, 
PDC11, TPi1p, ADH1, PGK1, GPM1) involved in glycolysis were confirmed. For instance, 
GAP1 protein was previously detected as cell surface antigen through indirect 
immunofluoresence (26). Moreover, work by Cutler’s group (91) demonstrated that glycopeptide 
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vaccines containing peptide moieties from FBA1, ENO1 and GAP1 could induce protection 
against candidiasis in a murine model.  An elegant study had been done to confirm that PGK 
protein was present in the cell wall by several approaches (2). Similarly, FBA1, PDC11, GPM1 
and TPi1p were detected in cell wall fractions by using 2D-gel based proteomic method (47) (20) 
(66). Heat shock protein like SSA1 and HSP60 had also been previously detected as cell wall 
proteins both in C. albicans (40) and S. cerevisiae (40). HSP90 (or its fragments) was isolated as 
a major antigen from the body fluids of patients 
with disseminated candidiasis (50), suggesting that it might be also a secreted protein. For these 
proteins with multiple cellular localizations, their functions in the cell wall were believed to be 
unrelated to their well known cytosolic functions. ADH1 was also proven to be critical in biofilm 
formation on catheter surfaces (53) and recently its existence on the cell surface was confirmed 
by a biotinylation technique (87). The high abundance of glycolytic enzymes in cell wall may be 
relevant to their roles in C. albicans pathogenesis. Previous studies indicated that those proteins 
were highly immunogenic in inducing host immune responses. (26) (32) (86) (75). Much 
attention has been drawn to these glycolytic enzymes in vaccine development regarding their 
function in stimulating immune response of host cells. ENO1 was viewed as an immuno-
dominant antigen as other conventional cytosolic proteins such as elongation factors and 
glycolytic enzymes in literature. For instance, one of the three cytosolic proteins (ACH1, ICL1, 
MLS1) identified in our study, ACH1 was well known for converting acetyl-Co A to/from 
acetate in cytosol , and its possible cell wall location has never been determined previously. 
However, ACH1(64)was detected in the serum specimens of candidiasis patients and showed 
high immunogenicity. Interestingly, work by Lorenz group (11) showed that a mutant strain 
lacking ACH1 is still fully virulent in a murine model. 
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Figure 4.5. Component classification of identified cell wall proteins based on GO Slim Mapper 
at CGD. The classification was based on annotation type selections for High-throughput 
Experiments and Manually Curated (the same for process classification in Figure 4.6). Out 
called figures represent the percentage of the number of classified proteins at the corresponding 
component over the total annotated proteins. The same proteins may be classified into two or 
more components. 
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MLS is an active enzyme in glyoxylate cycle which is required for wild-type virulence in murine 
systemic infection (41). 
 
Proteins normally observed in ribosomes were also found in our study. Many of these proteins 
like RPL10, RPL10A, RPL12, RPL13, RPL18, RPL19A, RPL23A, RPL32, RPL82, RPS10, can 
not be mapped by GO program at GCD due to no annotation for the specified GO Slim term in 
the selected annotation set. Therefore the real functions of these “ribosomal” proteins in cell wall 
need to be studied further in future. Other investigators also detected some ribosomal proteins 
(RPS4B, RPL3, RP10, RPL3 60S, RPL20B, RPP0)  in cell wall pellet fraction (20) of both yeast 
and hyphal forms; however possible cytosolic contaminations as a result of low speed 
centrifuging during cell wall pellet fractionation could not be ruled out. On the contrary, results 
from another group (66) did not include any ribosomal proteins even though the same cell wall 
preparation method and gel analysis were employed. It is possible that the “ribosomal” proteins 
may adventitiously bind to the cell wall after they escaped from the broken dead cells and react 
with the labeling reagents as discussed above. Although this possibility can not be totally ruled 
out, the extensive labeling of those “ribosomal” proteins suggests their localization on the cell 
surface. Additionally, RPL20B, RPP0, RPL3 60S, RP10 ribosomal proteins were also detected in 
the SDS-DTT resistant cell wall fraction(20), which should be free of any non-covalently 
associated proteins (including cytosolic proteins stuck to the plasma membrane or wall matrix) 
after extensive hot SDS washings. Therefore, these “ribosomal” proteins may be regarded as cell 
wall proteins rather than cytosolic contaminations. Study has shown that RP10 was 
immunogenic in human infection of C. albicans. (86) In Neisseria gonorrhoeae, RP L12 was 
believed to play an important role in invasion of human reproductive cells and shown to be 
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associated with the plasma membrane and exposed to the cell surface (81). Immunochemical 
assays would be needed to confirm the cell surface localization of any protein of interest 
identified in this study.  
 
 A group of elongation factor proteins (TEF1, EFT2, CEF3,EFB1) was identified in our study as 
well, which was consistent with reports from other investigators (20) (66). Interestingly, these 
proteins were reported to be absent on the cell wall of S. cerevisiae. Detection of these 
elongation factors have also been reported as extracellular or cell envelope associated protein in 
microbes such as C. albicans (44), Trichoderma.reesei (39) and Staphylococcus aureus (76). 
Moreover, the presence of TEF1 in tobacco cell walls has been confirmed by immunogold SEM 
analysis (94). Localization of TEF1 on the cell surface of C. albicans could also be supported by 
its ability to bind plasminogen (17).  The cytosolic functions of these proteins are related to 
protein synthesis and interactions with other proteins, but their roles on the cell wall are largely 
unknown. Although the approaches employed in our study minimized the possibility of cytosolic 
contamination, these possibilities still could not be ruled out: 1. Labeling reagents might react 
with those highly abundant cytosolic proteins in aging or non-viable cells whose disintegrating 
plasma membranes could not serve as barriers for the biotinylating reagents. 2. Certain channels 
(like Na+ ion channel) in plasma membrane could potentially uptake the sulfo-NHS-LC-biotin 
and sulfo-NHS-SS-biotin labeling reagents. Some researchers intended to accept the fact that 
these “ribosomal” proteins could indeed present in the cell wall possibly through the non-
canonical secretion pathways as mentioned earlier (59). Also, a series of histone-like proteins 
(HHT21, HHT3, HHF21, HTA1, HTB1) were detected in our study. Antigenic histone H2B-like 
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cell surface protein was also confirmed in Histoplasma capsulatum and predicted to be a new 
candidate antigen in vaccine development (60).  
 
4.4.4 Identified putative cell wall proteins classified into different cellular processes by GO 
(8) (4) 
The different roles of the identified proteins are summarized in Figure 4.6. The majority of 
proteins involved in the processes of interspecies interaction between organisms (17.7%), 
interaction with host (12.9%), carbohydrate metabolic process (8.8%), filamentous 
growth (8.2%) and pathogenesis (6.8%). Other proteins are mainly associated with other 
important biological processes such as hyphal growth, biofilm formation, cell wall organization 
and cell adhesion. Identification of proteins involved in the processes related to pathogen’s 
interaction with the host and other organisms suggests that those proteins are exposed to the 
extracellular environment and serve as initial points to interact with the host cells (e.g. adhesion, 
biofilm formation and recognition). Interspecies interaction between organisms generally 
includes interaction with hosts (HSP70, ADH1, PGK1, GPM1 and FBA) and symbiosis 
(encompassing mutualism through parasitism), which consists the response to defenses of other 
organism (through evasion or tolerance of defenses of other organism, MNT1), pathogenesis 
(CSH1, ECM33, PHR2, HSP90, BGL2, MNT1, ICL1, LPD1, MP65, BMH1), modification of 
morphology or physiology of other organism ( through induction by symbiont of host defense 
response, SSB1, HSP70, ACO1, TPI1, ADH1, MET6, CDC19, ENO1, PGK1, MP65, FBA1), 
adhesion to other organism (through adhesion to host, BGL2, PRA) and movement in 
environment of other organisms (through entry to host, ENO1). Also  21 (CSH1, SSB1, HSP70, 
ECM33, PHR2, HSP90, ALS4, TEF1, BGL2, PRA1, TPI1, ADH1, TSA1, MET6, CDC19,  
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Figure 4.6. Process classification of identified cell wall proteins based on GO Slim Mapper at 
CGD. Outcalled figures represent the percentage of the number of classified proteins involved in 
the corresponding process among the total annotated proteins. Same proteins may be classified 
into different processes. 
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ENO1, PGK1, GPM1, MP65, BMH1, FBA1) out of 26 proteins associated with interactions with 
organisms have been previously detected in the cell wall. It also should be noted that it is 
common that one protein can be found in different biological processes. For example, CSH1 
plays roles in pathogenesis (77), biofilm formation (58), and cell adhesion (78). ADH1 was 
classified into processes such as carbohydrate metabolism (85), generation of precursor 
metabolites and energy and biofilm formation (53) in addition to its involvement in the 
interaction with the host (17). MNT1 (54) was involved in interacting with the host (9), cell wall 
organization, filamentous growth and cell wall mannoprotein biosynthetic process. In addition to 
their roles in various interaction processes, ADH1, CDC19, ENO1, FBA1, GPM1, PGK1, TPI1, 
TSA1 are also involved in carbohydrate metabolic process (13). BGL2, BMH1, CSH1, ECM33, 
HSP90, ICL1, LPD1, MNT1, MP65, PHR2 were assigned as cell wall proteins that play 
important roles in C. albicans pathogenesis. MP65 was extensively studied for its capability to 
induce immune responses in humans (27, 28). ADH, FBA1, PGK1, TEF1, GMP1, TSA1 were 
among the eight cell wall proteins which had been shown to have the capability of binding to 
human plasminogen (17, 67). Recent work by Cutler and co-workers (91) demonstrated that 
peptide segments from FBA1, ENO1, GAP1, MET6, PGK1 could be conjugated to β-mannan 
trisaccharide [β-(Man)3] to produce novel glycopeptide vaccines against candidiasis in mice. The 
high effectiveness of protection induced by β-(Man)3-FBA1 and β-(Man)3-MET6 suggested that 
FBA1 and MET6 may be potent immunological proteins presented at the cell surface of C. 
albicans. Thirteen proteins are associated with the second largest process-carbohydrate 
metabolic process (based on their cytosolic functions): SRB1 in GDP-mannose biosynthesis; 
ENO1, PGK1,GPM1 and PCK1 in gluconeogenesis; ADH1,CDC19, ENO1, PGK1, GPM1 in 
glycolysis; MLS1, ICL1 in glyoxylate cycle; MNT1 in N-glycan processing; SRB1 in protein 
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amino acid glycosylation; MNT1 in protein amino acid O-linked glycosylation and MP65 in 
cellular glucan metabolism. Again, new cell wall functions of those well known cytosolic 
proteins have been being discovered and showed to be different from their primary roles in the 
carbohydrate metabolic pathway (59).  
 
Heat shock protein and chaperon proteins (HSP90, HSP70, HSP60, SSA1, SSA4, SSB1, SSC1, 
KAR2) are well known for their function to repair damaged proteins as a result of certain stress 
to the cell (e.g. drugs, heat and toxins) (37) (89), to maintain the integrity of the cell (42), and for 
their high immunogenicity in inducing host immune response in C. albicans pathogenesis. (46)  
Classification of those proteins indicated that also play other roles in other complicated 
biological processes. For example, HSP70, HSP90 and SSB1 were all classified as proteins 
interacting with host for their roles in response to the ligands released by other organisms. 
Additionally, HSP70 was identified as a cell envelope binding protein for human salivary histatin 
5 (38). Interestingly, HSP70 led to enhanced systemic candidasis in murine model due to its high 
immunogenicity. (10) Moreover, HSP70 proteins are also involved in many facets of proteins 
regulation including their folding and trafficking across the membrane (16). Also, Work by Piper 
(62) and Nombela’s (65) group suggested that HSP90 was responsive to pheromone in C. 
albicans infections and SSB1 was an immunoreactive protein in murine model, which indicated 
that these proteins somehow interacted with the host. Interestingly, the OG didn’t classify any 
heat shock proteins into cell adhesion process while HSP70 family proteins were viewed as 
major adhesins in a recent review article (13). Notably, for the first time we detected the Dnak-
type molecular chaperone (CA 0915), which was encoded by a gene about 50% identical to all 
eukaryotic HSP70s. However, very little information of this HSP can be found in literature. The 
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low abundance of this protein in the cell wall might be the main reason that it had never been 
detected before.  
 
Proteins involved in cell adhesion process also attract much attention from investigators who 
want to gain better understanding on the mechanism of the host-pathogen interactions. Proteins 
ALS4 (19), CSH1 (54, 78), MNT1 (54), MP65 (72), PRA1 (80) were classified in this process. 
As mentioned early, this GO classification does not include ECM33, HSP70 family proteins 
which, however, were usually considered as adhesins (13). 
 
4.4.5 Monitoring putative cell wall proteins during morphogenesis of C. albicans 
A SILAC based quantification approach was developed to monitor SDS-DTT extractable cell 
wall associated proteins during the transition of C. albicans from yeast and hyphae. Isotopic 
labeled lysine was incorporated into proteins synthesized during hyphae growth. To avoid 
potential cytosolic contaminations, it was first tried to label the hyphae cell surface proteins by 
sulfo-NHS-LC-biotin. However, the amount of biotinylated proteins extracted was too low for 
MS analysis, and such very low labeling efficiency was probably due to the sever aggregation of 
hyphae cells in PBS buffer. A classical approach to prepare cell wall pellet (66) (20) was 
employed in our study. Extensive washing of the cell wall fraction by gradient concentration of 
NaCl would significantly reduce cytosolic contamination; even though membrane associated 
proteins would co-precipitated with cell debris as well. Hot SDS-DTT extracted CWPs were first 
separated by 1D SDS-PAGE to reduce sample complexity and to increase sequence coverage. 
Fifteen major bands for each biological sample were cut for in-gel digestion followed by LC-MS 
and bioinformatics analyses of the tryptic peptides. A comparative analysis of those identified 
 140
proteins was performed by using Pepquan program (incorporated in BioWorks 3.1, Thermo 
Electron). The results indicted that ninety two proteins were up-regulated and twenty four 
proteins were down-regulated during the morphogenesis as shown in Table 4.2. For instance, 
ATP1 was slightly over-expressed in hyphae (in Figure 4.7) while expression level of ADH1 was 
significantly suppressed after the germination (Figure 4.8) as evidenced by SILAC quantitative 
analysis of pairs of  individual peptides differentially labeled by isotopic lysine.  
 
However, the degree of the regulation (H/L) was largely between 1.5:1 and 1:1.5 with the highest 
average ratio (H/L) being 3.26 for ACC1 and the lowest ratio (H/L) being 0.21 for ADH1 as 
shown in Figure 4.9, indicating that protein expression changes during the germination C. 
albicans was not large. This result is in good agreement with a previous study (47). Among the 
ninety two up-regulated proteins in response to germination, seven proteins (ACS2, HSP90, 
PSA1, SSA, SSB1, SSE1 and TUB2.3) were previously reported as being up-regulated in a 2-D 
gel based comparative analysis on SDS-DTT extracts of hyphae cells wall fraction (20). A recent 
report from Gil’s group (47) also confirmed some of those proteins (ACS2, SSB1) were up-
regulated. Notably, five heat shock proteins (HSP90, SSA1, SSB1, SSC1, SSE1) were all 
moderately up-regulated (from 1.31 to 1.51 fold) during two hour hyphae growth induced by 
temperature switch from 25°C to 37°. Up-regulation of those proteins may be explained by their 
primary function in heat shock protection. Similar expression level of SSB1 on yeast and hyphae 
cells was first predicted based on Northern-blot analysis by Gozalbo’s group (45) and its cell 
surface localization was also demonstrated by immuno-screening experiments. Previous study by 
Mukai and coworkers (52) also shown that mRNA levels increased by several-fold upon  
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Table 4.2 Summary of identified cell wall associated proteins (SDS-DTT extract)* 
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*These identified cell wall associated proteins in SDS-DTT fraction were differentially regulated 
between hyphae (H) and yeast (L) of C. albicans. Protein level up-regulated or down-regulated 
by at least 1.5 fold were considered significant and displayed in bold. 
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Figure 4.7 SILAC quantitative analysis of a protein extracted by SDS-DTT from cell wall pellet 
of hyphae of C. albicans. This protein (ATP1) is preferentially accumulated in yeast form (A) 
Part of full scan ESI mass spectrum acquired at time of 51.89 min. A peptide doublet indicated 
by a solid arrow represents a pair of peptide differentially labeled by an isotopic lysine residue in 
their sequence. The mass-to-charge (m/z) ratio of each peptide is 4.14 Da different. (B) Single 
ion chromatograms of the paired peptides eluted from C18 column at the same time window. The 
ratio (1:1.20) (H/L) calculated from peak area was used for average ratio calculation. Peptide 
sequence: Peptide precursor labeled by heavy isotopes (H): m/z 883.17; peptide precursor not 
labeled (L): m/z 879.03 
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Figure 4.8 SILAC quantitative analysis of a protein extracted by SDS-DTT from cell wall pellet 
of hyphae of C. albicans. This protein (ADH1) is preferentially accumulated in hyphal form (A) 
Part of full scan mass spectrum acquired through ESI at time of 52.47 minute. A peptide doublet 
indicated by a solid arrow represents a pair of peptide differentially labeled by an isotopic lysine 
residue in their sequence. The mass-to-charge (m/z) ratio of each peptide is separated by 2.57 
Da. (B) Single ion chromatograms of the paired peptides eluted from C18 column at the same 
time window. The ratio (4.16:1) (H/L) calculated from peak area was used for average ratio 
calculation. Peptide sequence: Peptide precursor labeled by heavy isotopes (H): m/z 676.78; 
peptide precursor not labeled (L): m/z 674.21 
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Figure 4.9. The overall graphic distribution of regulations of cell wall associated proteins during 
the yeast cells morphogenesis. The detailed regulation values of proteins (dots) were listed in 
Table 4.2. 
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induction to hyphae growth at 37°. However, work by Brwon’s group (84) shown that HSP90 
mRNA levels had no detectable increase as a result of germination. Our results suggest that there 
might be an opposite correlation of expression level between mRNA and protein. Moreover, a 
recent study published by Cowen’s group indicated that HSP90 played pivotal roles in regulating 
temperature-dependent morphogenesis by relieving HSP90-meidated repression of other relevant 
proteins through Ras1-PKA signaling cascade. (73) Compared to the larger set of up-regualated 
proteins during the morphogenesis, a small group of downregulated proteins was found to be 
mainly consisting of glycolysis enzymes (ADH1, PGK1, PFK2, GPM1, ENO1, CDC19). As 
mentioned above, the real functions of those moonlighting proteins in the cell wall remain 
enigmatic. Intriguingly, four human plasmin(ogen) binding proteins ( ENO1, ADH1, PGK1, 
GPM1) were found among those down-regulated proteins, which is consistent with a previous 
study (17) indicating that C. albicans cells bound to plasmin did not increase damages of 
endothelial cells.  Hyphae cells generally efficiently penetrate host cells through a combination 
of  factors that focuses hydraulic pressure at the hyphae tip via the activities of an array of 
secreted hydrolases (30); and it is further evidenced by our results that some hydrolase activity 
related proteins (ARF1, CEF3, HSP90, MSI3, SAP5, TIF andTFP1) are significantly up-
regulated. These hydrolases activity related proteins account for the highest function percentage 
(17.9% ) as classified at CGD. Interestingly, work by Cutler’s group showed that only moderate 
protection against candidiasis was achieved while mice were immunolized by synthetic vaccines 
containing peptide fragments from down-regulated GAP1 and ENO1 (91). Their finding might 
suggest that proteins highly down-regulated during the morphogenesis are presumably less 
immunologically relevant in eliciting protective antibodies from the host. Moreover, we 
tentatively propose IPF13485 as hyphae specific and IPF9550 as yeast specific. It should be 
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noted that despite some agreement with previous reports for both up and down regulated proteins 
(20) (47), our results also include proteins that showed opposite trend of regulation changes 
during the germination. For instance, ATP2, EGD2 were identified to be up-regulated in our 
study, but were reported as being down-regulated in a previous study (20). 
 
Proteins with significant regulation change (out of the range between 1.5:1 and 1:1.5 as indicated 
in bold type in Table 4.2 ) were classified according to their biological process by GO at CGD 
(4). Most of these proteins could not be mapped due to lack of evidence reported in the literature. 
Our biotinylation method confirmed the localization to cell surface of those proteins: ACC1, 
ACT1, ADH1, ADH2, ALD5, CDC19, CEF3, ECM33.3, ENO1, FAS2.5f, GAD1, GAP1, 
GND1, GPM1, HSP90, HXK2.3f, IPF14171, LPD1, PCK1, PDC, PET9, PGK1, POT14, QCR2, 
RPL82. It was also shown in our study that ENO1 may be highly abundant in yeast cell wall 
because of its largest sequence coverage (55.4%) among all identified biotinylated proteins. 
Given that ENO1 was only moderately down-regulated (H/L, 1:2.23) and its low sequence 
coverage (23.41%) even after 1D SDS-PAGE gel separation, we speculated that our biotinylation 
labeling approach was biased toward proteins located on cell surface. The largest group for up-
regulated proteins (SAP5, FAS2, ECM33, LPD1, HSP90) belong to the process of interspecies 
interaction between organisms and pathogenesis. Likewise down-regulated proteins (ENO1 
ADH1 PGK1 GPM1 CDC19) were also classified in interspecies interaction between organisms 
(including with the host). Lee’s group (14) first detected SAP4-7 proteins in culture supernatants 
from hyphae cells and monitored their dynamic expression levels during different germination 
stages under various pH conditions. The pathogenicity of SAPs from various C. albicans strains 
was reviewed by Cassone (18). A recent review paper from Hube’s group summarized the roles 
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that secreted aspartyl proteinases (SAPs) family played in C. albicans’ interaction with host and 
pointed to their direct contribution in its pathogenicity (56). Detection of SAP5 in our study 
indicated that certain secreted proteins may also be non-covalently associated with cell wall and 
therefore susceptible to SDS-DTT extraction. Contrary to the claim of Pinto’s group (20) that 
FAS2 and LPD1was only detected from SDS-DTT resisted hyphae cell wall fraction, our result 
showed that both proteins were up-regulated in hyphae cells and both also presented in yeast and 
were SDS-DTT extractible. This suggests that our approach was quite sensitive in the detection 
of low abundant proteins. Moreover, LPD1 were identified as labeled protein by sulfo-NHS-SS-
biotin and FAS2 were also detected based on one peptide modified by I-biotin. FAS2 has also 
been found in membrane-coated organelles and known for its essential role in the survival of the 
yeast in non-exogenous fatty acid environment (79). Work by Nguyen’s group (15) suggested 
that LPD1 could be released from cytosol to the cell surface after the cell being attacked and 
damaged by the human immune system, and serve as an immunogenic antigen. Its 
immunogenicity was confirmed in murine model recently by Gil’s group (24).  
 
4.5 Conclusions 
In summary, one hundred and forty eight CWPs from C. albicans yeast cell were identified 
based on the detection of biotinylated peptides and observation of characteristic fragments 
originated from the biotin moiety on MS2 spectra of labeled peptide. The method developed in 
our study, to our knowledge, is the most accurate approach for efficient identification of CWPs 
and cell wall associated proteins of C. albicans. Fifty one of one hundred forty eight proteins 
were never reported before in the literature. Each approach involved with one of the three 
labeling reagents has its own protein identifications, while some other protein identifications 
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were shared by at least two labeling approaches even though the detected labeled peptide might 
not be necessarily the same. Moreover, two hundred and thirty five cell wall-associated proteins 
were identified from cell wall pellet of hyphae of C. albicans after SDS-DTT extraction. 
Analyzed by this SILAC based comparative proteomic approach, ninety two proteins were 
upregulated and twenty four proteins were downregulated during the transition from yeast to 
hyphae growth. IPF 9550 (CA4570) and IPF 13485 (CA1019) were tentatively assigned as yeast 
and hyphae specific protein respectively. Overall the expression level change ranged from 3.26 
fold upregulation and 0.21 fold downregulation after the morphological transition from yeast to 
hyphae. Thirty nine proteins were significantly upregulated (more than 1.5 fold increase) and 
thirteen proteins were significantly downregualted (more than 1.5 fold decrease) in hyphae cells. 
According to the functional classification obtained from CGD, seven upregulated proteins were 
related to hydrolase enzymatic activities which might be promoted in cell wall during 
germination, while four major plasmin(ogen) binding proteins were downregulated possibly to 
facilitate germ tube elongation. This extensive study on cell surface proteome analysis of C. 
albicans will help elucidate the mechanism of host-pathogen interaction and guide in protective 
vaccine development in future.  
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APPENDIX 
 
Table S1. Summary of CWPs identified through cell surface biotinylation and LC-MS in 
Chapter 4 
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Note: K& indicates that lysine residue was labeled by sulfo-NHS-LC-biotin. K+ indicates that 
lysine residue was labeled by sulfo-NHS-SS-biotin. C# indicates that cysteine residue was 
labeled by iodoacetyl-PEO2-biotin. C@ shows that cysteine residue was modified by IA before 
trypsin digestion. M* shows that methionine was oxidized. Green highlighted proteins were 
those reported for the first time. 
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